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ABSTRACT 
Using bioartificial kidney is the promising approach for removal of non-dializable, protein-
bound uremic toxins, which are responsible for high mortality and morbidity in treating kidney failure 
related conditions. Additionaly, bioartificial kidney device could perform the physiological roles of the 
kidney such as metabolic replacement, endocrine function and immunomodulation. 
In the current work two commercial polyethersulfone-based membranes, Gambro HCO 1100 
and Membrana MicroPES TF10 used in haemofiltration and plasma separation applications 
respectively were investigated. To provide adequate cytocompatibility of the membrane biomimetic, 
biomimetic double layer coating was developed. First, the membranes were coated with mussel-
inspired synthetic polydopamine film, following with the coating of Collagen Type IV. 
Transport properties of the coated and native membranes were investigated. Increase in pure 
water permeability of the coated HCO 1100 membranes was observed. Membrane surface 
hydrophilization was assumed as the major factor responsible for the effect. Membrane permeabilities 
for bovine serum albumin and immunoglobulin G solutions were studied. Significant increase in 
protein rejection was observed for double coated HCO 1100 membranes with small or no effect of the 
double coated MicroPES TF10 membranes. 
Next, formation of confluent monolayers of the renal epithelial cells on the membrane scaffolds 
was studied. Cell seeding strategy was developed and two seeding conditions were tested. Specifically, 
the cells were allowed to adhere to the biomimetic membranes passively, and the negative pressure 
was applied to facilitate cell adhesion. After cultivation in semi-batch conditions the monolayer 
formation was examined. Confluent monolayers were observed for the conditions with passive cell 
adherence for the both membranes. Cell contacts formation and cell polarization were confirmed with 
the staining for ZO-1 protein. Applying the pressure to facilitate cell adhesion, on the contrary, 
resulted in the loss of cell ability to form functional monolayers. 
 
Keywords 
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1. INTRODUCTION 
1.1. Background and motivation 
 
Several million people dies per year worldwide from a severe a condition with limited 
understanding of its pathophysiology and the methods of its treatment called acute kidney injury. 
Much more people require permanent hospitalization for treatment of its complications such as tubular 
necrosis, hepatorenal syndrome, rhabdomyolysis, sepsis, cardiorenal syndrome etc. Acute kidney 
injury is a syndrome which is related to unexplainably high mortality rates, high morbidity for which 
no effective commonly accepted treatment exists today. 
Understanding of the acute kidney injury is limited first of all because of its extremely fast 
progression in patients. Most information on the mechanisms of the syndrome was obtained from 
animal models and from a condition called chronic kidney disease. However, the information obtained 
from both sources may not be extrapolated on the acute kidney injury conditions.  
Uremic toxins are proposed to link kidney failure with high mortality rates and various renal 
and non-renal pathologies. Specific cluster of non-dializable, protein-bound uremic toxins comprises 
the group of 25 solutes requires the special attention due to their diverse and severe toxicity. The 
removal of such solutes from the bloodstream is obscured owing to their protein bound state. 
Numerous traditional strategies exist to overcome these limitations. Examples of such approaches are 
an increase in duration  and frequency of haemodialysis and / or increase of the mass transfer 
coefficient of the dialyzer. However only below 20 % toxin removal improvement was reported. 
Therefore there is the strong necessity of developing novel successful strategy to remove protein-
bound uremic toxins. 
Such novel approaches include using protein-leaking membranes and various adsorption 
strategis (polymethylmethacrylate membranes, hemoperfusion, mixed matrix membranes, 
albumin dialysis). Another promising strategy in treating kidney failure related condition is in 
using bioartificial kidney. Organic anion and cation transporters present in renal proximal 
epithelial cells are capable of specific, unidirectional transport of protein-bound uremic 
toxins. Moreover, in addition to the toxin removal bioartificial kidney device could perform 
other physiological roles of the kidney such as metabolic replacement, endocrine function and 
immunomodulation. 
Bioartificial kidney is a bioreactor system, typically consisting of hollow fiber membranes and 
is seeded with functional epithelial cells from kidney proximal tubules. The specified cells are of the 
major interest since they perform the most of the active reabsorption in the nephron. Moreover, the 
cells are able to replace other physiological functions of kidney. The bioreactor seeded with the 
proximal tubular cells is traditionally called renal assist device. 
Positive results were obtained in bioartificial kidney development using human and animal 
derived immortalized cell lines. However, only limited success was achieved when using human 
primary tubular cells, which are preferred for clinical applications. The nature of these cells is more 
demanding to the chemical or mechanical signals that triggers their growth and differenciation. It 
became evident that successful transport of the uremic toxins by the epithelial cells could only be 
possible in case of formation of polarized monolayer. In such polarized cells apical and basal parts are 
performing different functions. Formation of tight junctions is one of the keys that triggers cell 
polarization and impaired tight junction formation corresponds to the loss of the transport properties of 
the cells. 
Therefore, membrane properties plays critical role in bioartificial kidney development. Being 
used in contact with blood requires sufficient hemocompatible properties of the membrane. Sufficient 
membrane transport should be assured for the duration of at least 100 h. And finally the membrane 
should promote and facilitate cell attachment differentiation and proliferation. 
Using commercial membranes currently applied in hemodialysis/hemofiltration in development 
of bioartificial kidney is the common strategy, considering the membrane requirements. However, in 
most of the membrane surface modification is required to promote cell performance. The parameters 
of membrane topography such as roughness, porosity and the pore size also must be considered.  
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1.2. Objectives 
Therefore, taking into account all of above two types of commercial membranes (Gambro HCO 
1100 and Membrana MicroPES TF10) used in hemofiltration and plasma separation were selected to 
be tested as scaffolds for human primary tubular cells. To perform the study on the basis of the 
literature data the following objectives were established: 
• Develop and biomimetic coating the outer surface of the membrane hollow fibers using 
mussel-inspired synthetic coating with poly-L-DOPA and the components of 
extracellular matrix; 
• Characterize transport properties of the coated membranes; 
• Establish confluent functional monolayer of primary human tubular cells on the outer 
surface of the fibers. 
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2. LITERATURE REVIEW 
2.1 Acute kidney injury overview 
Acute kidney injury (AKI), formerly known as acute renal failure, is a syndrome with the 
complex etiology and it is generally characterized as an abrupt loss of kidney function, which develops 
within the time up to one week. Due to the numerous causes of the syndrome, no commonly accepted 
definition exists nowadays.  
The concept of the syndrome have been evolving in the last 50 years and various attempts were 
made to standardize and classify renal dysfunction. The first consensus definition of acute renal failure 
that was broadly supported had been developed by Acute Dialysis Quality Initiative group [1] and 
published in 2004 [2]. The concept was called RIFLE using such categories as: Risk, Injury, Failure, 
Loss of function, and End-stage renal disease as the stages of AKI severity. The concept was 
designated to diagnose the presence or absence of AKI in patients, as well as for determining the 
severity of the condition. It is worth mentioning that the system neither aimed to predict the mortality 
or the outcome nor intended to recommend the specific therapeutic treatment of the patients.  
However, since even the small rises in serum creatinine levels corresponded to elevated 
mortality in patients, the term acute kidney injury has later been used to emphasize the importance of 
whole range of  renal dysfunction from its onset to the long-term failure and not only the stage of 
failure itself. Therefore, in order to overcome some of the existing limitations , AKI Network [3] 
developed another classification based on the RIFLE system in 2007 [4]. The both RIFLE and AKIN 
systems are common for clinical practice and use the sudden increase of serum creatinine levels and/or 
oliguria as main diagnostic criteria (Detailed specifications of the criteria used for RIFLE and AKIN 
classifications are given in Appendix A). But in spite of relative simplicity of the diagnostics, the 
above approaches have some limitations. The both systems use alterations in urea output and 
creatinine levels from hypothetical baseline, the symptoms which emerge relatively late after injury 
had occurred. Also, neither of the approaches addresses the question about the nature nor the site of 
the injury. Therefore, more research is required for investigation of the new biomarkers of AKI for the 
more specific diagnostics [4–7]. 
Incidence and severity of AKI vary among populations and communities of people. 
Accordingly, occurrence of AKI when no dialysis treatment is required is estimated as 5000 cases per 
million per year. Whereas about 300 cases per million per year are reported for dialysis-required 
patients worldwide. Prevalence of AKI varies also geographically. Thus, in developing countries AKI 
is often induced with hypovolaemia secondary to diarrhea. Whereas in developed countries major 
surgeries, especially open heart surgeries, are common cause of the disease [8]. 
Among the general triggers of the disease are such conditions as: inflammatory process in the 
kidney, renal ischemia (restriction of blood supply), nephrotoxins exposure etc.. Occurrence of AKI is 
common in hospitalized patients, especially the ones undergoing major surgery and is very common in 
critically ill patients.  
Overall, two different group of patients with AKI could be distinguished. In the first case, AKI 
usually originates from using nephrotoxins such as steroidal anti-inflammatory drugs, some antibiotics 
vasoconstrictors or of such conditions as glomerulonephritis or rhabdomyolysis. In all of above 
patients, AKI is restricted to the single organ and the overall prognosis is positive with the mortality 
rate of 8 %. 
On the other hand, tremendous difference  is observed in patients with AKI when multiple 
organ failure is present. The presence of AKI in this case could be regarded as an indicator of severity 
of underlying pathology. It is this form of acute kidney injury, triggered generally by prerenal factors, 
which is the most common form of the disease in the developed countries and among critically ill 
patients. Here, the mortality rates remain at extremely high levels of higher than 60% in the intensive 
care units worldwide. The overview of AKI epidemiology is shown in Fig. 2.1. [5,7–9]. 
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Limited understanding of the mechanisms of AKI, and as a result, the of the methods of its 
treatment, results in high morbidity and mortality rates. The main progress of understanding 
concerning the mechanisms of AKI is obtained from works on animals. There are three main types of 
animal models that are used to investigate AKI. Namely they are ischemia, sepsis and toxins models. 
The strong discussion is present concerning relevance, applicability and reproducibility of these 
models in critically ill patients [2]. 
Nonetheless, it is becoming clear that renal injury is able to cause in the injury of other organs 
through yet unclear pathways, which are still have to be investigated. The phenomenon is called organ 
cross-talk, which underlines the complexity of the condition. Such complications can be further 
categorized in the following conditions:  
 
• Hepatorenal syndrome 
• Rhabdomyolysis 
• Sepsis 
• Cardiorenal syndrome [8,10]. 
 
As it could be seen from above, that even short-term kidney injury could result in the prolonged 
morbidity and mortality. Bellomo at al.[8]  in their work attempted to summarize the evolution of 
AKI, which could be schematically represented in Fig. 2.2. 
 
Fig. 2.1. Causes of acute kidney injury [9]. 
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2.2 Uremic toxins in acute kidney injury 
As it could be seen from above, the most severe form of AKI is associated with the increased 
mortality in patients. The condition is related with non-renal pathologies such as lung, liver and heart 
failure, sepsis etc. Uremic toxins could represent the connection between the renal and non-renal 
manifestations of AKI, since the damage to the non-renal organs can be explained by their action [11]. 
In the both cases of AKI and chronic kidney disease (CKD), uremia initially results from 
decrease of glomerular filtration rate and urine output, which in turn leads to the retention of the 
nitrogenous and non-nitrogenous waste products, metabolic acidosis, hyperkalemia and hypervolemia. 
It should be mentioned, that most of the uremic toxins were previously studied and characterized for 
chronic kidney disease and the investigation of the uremic toxins in AKI is still in its infancy. 
Investigations are mainly obscured due to the fact of the specificity of the toxins types according to the 
form of AKI and the transient, rapidly changing nature of uremic toxins levels. Whereas, in CKD the 
steady-state conditions could be observed [9,11].  
Traditionally uremic toxins for both AKI and CKD fall into the following categories: 
• Small water-soluble molecules, MW < 500 Da 
• Protein-bound molecules 
• Middle molecules, MW > 500 [9,11]. 
More refined view on the toxins was proposed by Uremic Toxin Work Group (EUTox) in 2003 
[12]. In the extensive study 90 uremic solutes were investigated. Majority of toxins investigated (68 
solutes) were small molecules with molecular weight <500 Da. The second largest group of the toxins 
were protein-bound solutes, comprising of 25 molecules (~ 30 %), with all but two toxins having 
MW<500 Da. Concentrations of these substances ranged from 32.0 ng/L for methionine-enkephalin up 
to 2.3 g/L for urea. Moreover, inorganic substances such as PO43-, SO42-, Cl-, K+, Na+, Ca2+ etc., can 
also be regarded as toxic substances in uremic conditions. Specifically increase of NaCl concentration 
results in dramatic effect on cardiovascular system, whereas accumulation of calcium phosphates 
results in vascular blockage. The extensive lists of the investigated toxins and their physiological 
parameters are given in Appendix B [12,13]. 
As it could be seen from above, low molecular weight compounds comprise the vast majority of 
the uremic toxins. But the importance of this group of compounds lies not only in the abundance but 
also in its diverse toxicity. Distinctive feature of this group of molecules is their action on several or 
 
Fig. 2.2. Acute kidney injury progress. GFR, glomerular filtration rate. NGAL, neutrophil gelatinase-
associated lipocalin. Cys C, cystain C. KIM-1, kidney injury molecule 1. IL-18, interleukin 18. GST, 
glutathione-S-transferase. L-FABP, liver fatty-acid-binding protein. CRP, C reactive protein. IL-6, 
interleukin 6 [8]. 
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multiple systems of the organism. To illustrate the above statement, the following table summarizes 
selected low molecular weight uremic toxins and the main of investigated actions on the specific 
systems. 
Table 2.1. Toxicity profiles of selected uremic solutes 
Uremic Toxin Structural Formula Toxicity Reference 
Indoxyl Sulfate 
 • Nephrotoxicity (tubular fibrosis and glomerular 
sclerosis) 
• Promotion of transforming growth factor beta 
expression 
• Induction of oxidative stress in in tubular cells, 
mesangial cells, vascular smooth muscle cells, 
endothelial cells and osteoblasts as well as stimulating 
aortic calcification 
• Promotion of cardiovascular disease and 
osteodystrophy 
• Central nervous system toxicity 
Niwa 2010, 
[14] 
 
 
D'Hooge et 
al., 2003 
[15] 
Asymmetric 
Dimethylarginine 
(ADMA) 
 
• Promotes inflammation 
• Kidney enzymes inhibition 
• Endothelial and vascular damage, vasoconstriction, 
increased blood pressure through endothelial NO 
synthase inhibition 
Cardounel 
et al., 2007, 
[16] 
Homocysteine 
 • Oxidative stress via producing of reactive oxygen 
species 
• Protein binding and modification and enzyme 
inhibition 
• Arterial occlusion and vascular damage 
Perna et al., 
2003, [17] 
Guanidines, 
(Methylguanidine) 
 
• Proinflammatory effects on leukocytes 
• Stimulation of production of Tumor necrosis factor 
alpha 
• Central nervous system toxicity 
(Guanidinosuccinate) 
Glorieux et 
al., 2004 
[18] 
D'Hooge et 
al.,2003 
[15] 
3-carboxy-4-
methyl-5-propyl-2-
furanpropionate 
(CMPF) 
 
• Oxidative damage in renal tubular cells 
• Inhibition of organic acid transport at brain/blood 
barrier, uremic ecelophaty 
• Toxicity to mitochondria, liver enzymes and 
erythroid blood cells 
Miyamoto 
et al., 2012, 
[19] 
Action on multiple systems of the organisms generally characteristic for middle molecules with 
molecular weight of 500 – 12.000 Da. Typically these compounds are of the peptide nature and often 
interfere with immune and cardiovascular functions. Specifically, elevated concentrations of various 
potent proinflammatory cytokines such as: Interleukins -6, -1, -18, Tumor necrosis factor –α were 
observed in the conditions of uremia. Which in turn, result in inflammation in such organs and systems 
as lung, kidney tubules, central nervous system [11]. 
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Decrease of immune defense, through different mechanisms, in uremic patients is linked the 
increased levels of such molecules as: Granulocyte-inhibiting protein I, κ- and λ-Light chains of 
immunoglobulins etc [9]. 
Low levels K+ and high PO43- levels in kidney failure conditions result in the production of 
excess of Parathyroid hormone. Which, in turn, triggers the systemic uptake of calcium into the cells 
and further modifications of critical physiological functions [9,13]. 
Another, well studied uremic peptide is β2-Microglobulin. The molecule is related to late stages 
of renal injury and amyloidosis. This peptide of 11.8 kDa is often used as a marker of large molecules 
removal with dialysis treatment [9,13]. 
As it was mentioned previously, AKI and CKD manifestation results in the damage of kidney 
tubular cells, namely tubular necrosis through complex interrelated mechanisms. In the normal 
physiology, renal tubules are exposed to approximately 150 L/day of glomerular ultrafiltrate. 
Consequently, in the renal tubules takes place reabsorbtion of low molecular weight proteins, amino 
acids, glucose, up to 90% of phosphate and 80% and 60% of bicarbonate and chloride respectively. 
Additionally there are also being removed the  numerous endogenous and exogenous substances and 
performed endocrine and paracrine functions. Therefore, proximal and distal tubular cells are 
responsible for active secretion of uremic toxins from blood into urine and have numerous specialized 
secretion and enzymatic systems expressed on their surface. Specifically, organic anions and cations, 
which represent the largest group of uremic toxins, are transported with unidirectional transcellular 
transport. Namely, toxin uptake takes place by the transporter at the basolateral membrane at the blood 
side with its consecutive secretion into urine by the transporter at the brush border membrane 
[5,20,21]. 
The example of indoxyl sulfate elimination from bloodstream could be used to illustrate the 
toxin transport in the proximal tubular cells. Indoxyl sulfate could only be transported in these cells by 
the organic anion transporters (OAT) since it is  almost exclusively bound to the albumin in the blood. 
These transporters are responsible for the uptake and/or secretion of the specified uremic toxin and the 
other endogenous and exogenous organic anions, including various drugs. Therefore, since indoxyl 
sulfate is a physiological ligand for OATs, its increased levels in uremic conditions leads to the 
accumulation of the toxin within renal tubular cells and their subsequent damage. Schematic 
representation of unidirectional indoxyl sulfate transport is given in the following graph [13,21,22]. 
 
To conclude, as it could be seen from above that uremic toxins showed strong involvement in 
the progression and pathology of acute kidney injury and chronic kidney disease. Renal tubular cells 
serve as the organism’s primary defense line against toxic uremic substances. Consequently, such 
conditions as glomerular and tubular necrosis and tubular fibrosis are diagnostic conditions generally 
present in AKI or CKD. 
2.3 Traditional management of the uremic toxins 
Wide range of metabolic diversity is performed by the kidney. One of the most crucial role of 
the kidney for the organism is its excretory function where kidney is responsible for removal of 
thousands of different chemicals from the bloodstream. Therefore, as it was discussed before, loss of 
 
Fig. 2.3. Indoxyl sulfate transport by organic anion transporters in kidney tubular cells [22,22]. 
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the function of the kidney results in the toxins accumulation in the blood. The toxins produced during 
nitrogen metabolism, such urea, are of particular importance since the large amounts they are 
produced and their high toxicity [23]. 
Extracorporeal devices, therefore, are often applied to eliminate the toxins from the blood. In 
such devices, normally small flow of blood is removed continuously from the patient and returned 
back to the patient after treatment. Normally toxin molecules are removed from blood to the dialysate 
side by diffusion through semipermeable membrane. Flow rates of blood are usually 100 – 500 
mL/min and the total volume of the extracorporeal blood circuit is usually several hundred milliliters . 
Dialysate circuit is usually applied in the counter current mode. For optimal blood purification the 
ratio between dialysis fluid and blood flow rates must be around 1.5 – 2. For higher ratios result in 
little increase of toxin removal and for lower ratios significant reduction of clearance rates was 
observed. Most dialysis machines work in fixed dialysate flow rate of 500 mL/min, which require 120 
L of dialysate for 4 h of operation. Normally this amount of fluid is prepared by dilution of 
concentrated electrolyte and buffer solution with purified water [23,24]. 
Chemical extraction from blood is controlled by the permeability characteristics of the 
membrane and the flow rates of blood and dialysate Qb and Qd respectively. Applying mass balance to 
the blood and dialysate compartments it is possible to describe overall effect of the dialyzer [23]: 
𝑁𝑡=𝑄𝑏�𝐶𝑏𝑖𝑛 − 𝐶𝑏𝑜𝑢𝑡� = 𝑄𝑑(𝐶𝑑𝑜𝑢𝑡 − 𝐶𝑑𝑖𝑛) (2.1) 
where: 
𝑁𝑡 – total removal rate of the solute, mol/min); 
Qb, Qd – blood and dialysate flow rate, mL/min; 
Cb, Cd – molar concentration of the component in blood and dialysate compartments . 
 
The effectiveness of separation of the compounds in hemodialysis is normally described by the 
term “clearance,” which describes removal rate in ml/min. The expression of clearance in three 
different modes of operaion – hemodialysis (2.2), hemofiltration (2.3) and hemodiafiltration (2.4) are 
described using following equations [25]: 
 
𝐶𝐿=
𝑄𝑏(𝐶𝑏𝑖𝑛 − 𝐶𝑏𝑜𝑢𝑡)
𝐶𝑏𝑖𝑛
=
𝑁𝑡
𝐶𝑏𝑖𝑛
 
𝐶𝐿=
𝐶𝑓
𝐶𝑏𝑖𝑛
𝑄𝑓 
𝐶𝐿=
𝑄𝑏�𝐶𝑏𝑖𝑛 − 𝐶𝑏𝑜𝑢𝑡� + 𝑄𝑓 · 𝐶𝑏𝑜𝑢𝑡
𝐶𝑏𝑖𝑛
 
(2.2) 
 
 
(2.3) 
 
(2.4) 
where: 
CL – solute clearance; 
𝑄𝑓 – filtrate flow rate; 
𝐶𝑓 – molar concentration of the compound in the filtrate. 
 
Common indicator of dialysis efficiency is the clearance of uremic toxins. Using the membrane 
with ~60 kDa cutoff urea is classified as low molecular weight substance and can be completely 
removed by dialysis. For higher molecular weight compounds, such as vitamin B12 (1355 Da) or inulin 
(5200 Da) lower clearances have been observed. Blood flow is the one of the most important 
characteristics for the clearance of compounds. At low blood flows clearance increases linearly with 
the blood flow and reaches plateau for higher flows. Also, it is worth mentioning, that at low blood 
flows the clearance is fully controlled by dialysate flow [25]. 
Two groups of materials are used in modern dialyzers: 
• cellulose based  
• synthetic. 
Cellulose membranes are made of reconstituted cellulose and are relatively inexpensive. The 
main drawback of this type of material is the significant levels of complement activation due to the 
presence of high amount of hydroxyl residues. Cellulose OH group substitution can result in less 
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amount of complement activation but on the other hand results in increased blood coagulation which 
requires increase of anticoagulant treatment [24]. 
The main fraction of the dialyzers used worldwide is represented by synthetic materials. Variety 
of polymers and their mixtures are used to obtain optimal performance. Specifically, ultrafiltration 
coefficient or hydraulic permeability are the parameters that divide HD membranes into the two 
categories: low- and high-flux. Application of either type of the membrane depends on the case, but, 
for example, in Europe high-flux membranes are normally applied for the patients with chronic renal 
failure [26]. High-flux dialyzers are typically made of synthetic membranes and achieve ultrafiltration 
coefficients ~ 60 mL/Min∙mmHg. They have higher molecular weight cutoff and greater convective 
permeability to the middle molecules 5 – 25 kDa. As a materials for such membranes are commonly 
used PMAA, PAN, PES etc [24,25]. 
The membrane materials used in the current work are based on the mixtures of PES/PVP/PA  
and PES/PVP for Gambro HCO 1100® (Gambro Dialysatoren GmbH, Hechingen, Germany) and 
MicroPES® TF10 (Membrana GmbH, Germany) respectively. Specifications of the specified 
membranes are given in Appendices C and D. 
2.4 Protein-bound uremic toxins and their treatment 
Special group of uremic toxins comprises protein-bound solutes. Protein binding of these 
molecules results in major limitations for their effective clearance through hemodialysis. Traditional 
hemodialysis becomes inefficient at high toxin binding ratios, since only small part of toxins is able to 
diffuse through the membrane. Performing hemofiltration with the membranes having higher cut-off 
values, could improve clearances, by increasing convective component of the transport, but still 
efficiency of the process is low due to the high protein binding [27]. 
Comprehensive list of 25 protein-bound solutes is given in Appendix B. For such molecules as 
3-Deoxyglucosone, N-(carboxymethyl)lysine, indoxyl sulfate, leptin, and 3-carboxy-4-methyl-5-
propyl-2-furanpropionic acid (CMPF) more than 5-fold increase of concentrations was observed in 
uremic conditions [13]. 
In uremic conditions, human serum albumin serves a major ligand for protein-bound toxins. In 
normal physiology, albumin, being predominant protein in serum, acts as circulating ligand and free 
radical scavenger. In uremic conditions, however, albumin is subjected to various post translational 
modifications. Most common examples are thiolation, carbonylation, glycation and oxidation. 
Generally, such modifications result in the increase of the negative charge of serum albumin and the 
exposure of its hydrophobic regions. Functionally, it results in impaired ligand binding capability and 
decreased antioxidant activity. Above considerations are presented schematically in Fig. 2.4 [28–32]. 
 
Fig. 2.4. Effect of serum albumin modifications in uremic conditions [29]. 
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Whereas the most of the protein-bound toxins interact with albumin, retinol-binding protein, 
could be an example of the exception to general rule. Retinol-binding protein is a protein of 21 kDa 
and 90% of it is bound to a carrier of thyroid hormone – transthyretin [13]. 
As it can be deduced, therapeutic difficulty to remove bound substances in HD is directly linked 
to the binding ratio of the toxins. Such molecules as indoxyl sulfate,p-cresyl sulfate, CMPF, and 4-
ethylphenyl sulfate exhibit especially high protein-binding ratios of more than 90%. As a result, less 
than 35% of the specified toxins could be removed with conventional therapy. Interestingly, that for 
such potent uremic toxin as CMPF, with exceptionally high albumin binding ratios of more than 95%, 
after HD treatment in patients was observed 15% increase in its concentration. Therefore, CMPF 
removal is impossible with HD due to its strong albumin binding [33,34]. 
Several approaches have been used to overcome the specified limitation. Traditional therapy 
involves an increase in duration  and frequency of HD. Another approach implies an increase of 
dialysate flow rate 𝑄𝑑 and improvement of the membrane mass transfer coefficient. However, only 
minor improvement in removal efficiency could be achieved with the traditional therapy, which in turn 
results in the strong necessity for alternative, more efficient strategies [29]. 
One of the first examples of such untraditional therapy was using of protein-leaking membranes 
for HD treatment. Such effect could be achieved by using larger pore size and high porosity materials. 
Specifically, protein-leaking hemodialysis when using BK-F polymethylmethacrylate membrane 
(Toray Medical Co., Chiba, Japan) is shown to decrease CMPF serum levels by 50%. Also, using such 
membranes let significantly improve removal of middle molecules, such as pro-inflammatory 
cytokines, light chains of immunoglobulins, β2-microglobulin etc. Another example of such protein 
leaking membranes, successfully used in therapy is Gambro HCO 1100® (Gambro Dialysatoren 
GmbH, Hechingen, Germany) dialyzer, which is reported to successfully remove immunoglobulins 
light chains in variety of the therapeutic conditions, including AKI  [34,35].  
Alternative approach involves the use of various adsorption methods. Such effects could be 
obtained by the action of membrane itself, as it was reported in case of polymethylmethacrylate 
[36,37]. Different variations of this approach involving applications of natural or synthetic adsorbents 
for protein-bound toxin trapping were also reported in the literature. Direct adsorption from blood in 
packed columns (hemoperfusion) is still in its underdeveloped stage mainly due to the low 
hemocompatibility of such treatment [38,39]. Similarly, Meyer et al. report the increase in protein-
bound toxin clearances when using synthetic adsorbent (activated charcoal) in the dialysate fluid [40]. 
Using mixed matrix membranes could combine the advantages of using the adsorbent and have 
excellent hemocombatibility properties. Recent work of Tijink et al. [41] could be regarded as an 
example for this approach. Yet another strategy for protein-bound toxins trapping, is in using natural 
adsorbents. In analogy to the synthetic adsorbents, albumin dialysis therapy, used in liver failure could 
be applied for bound solutes displacement from uremic albumin, therefor preventing undesirable 
protein modifications. Successful examples of such treatments are Molecular Adsorbent Recirculation 
System (MARS), Single-Pass Albumin Dialysis (SPAD) and the Prometheus systems [29,39]. 
Yet another approach to overcome uremic solutes related conditions, as it was demonstrated by 
Kikuchi et al. [42] is in using of oral sorbents. Since such potent uremic toxins as IS originate from 
colon microflora, therefore such therapy could be regarded as very attractive approach. 
However, it is worth mentioning, that all of above examples of protein bound toxins treatments 
are generally supportive in their nature. Despite of the numerous attempts to overcome the limitations 
for the protein bound toxins removal, existing techniques still demonstrate to fail in preventing severe 
medical conditions related to kidney injury with unacceptable high mortality levels. Existing therapies 
are unable to substitute numerous kidney functions such as metabolic, regulatory, endocrine etc. which 
can be crucial for the positive dynamics in the therapy. Therefore using bioartificial kidney can be 
regarded as an attractive approach in solving kidney-related conditions [13,29,34,39]. Overview of the 
state of the art in the bioartificial kidney development is given in the next section. 
2.5. State of the art of bioartificial kidney development 
The field of bioartificial kidney (BAK) evolutionary emerged from hemodialysis applications in 
the late 90s. Two research groups led by A. Saito (Japan) [21,43] and Humes H.D. (USA) [44–46] 
contributed the most in the early development of BAK. In their work, the authors connected in series 
BAK device to the hemodialyzer module. Using hemodializers to substitute the function of impaired 
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glomerular filtration is a commonly accepted strategy [24]. By connecting bioreactor unit to the 
hemodialyzer outlet authors intended to substitute the functions of kidney tubules, such as 
reabsorbtion of the nutrients, producing of hormones and cytokines and which is the most important, 
excretion of the toxins. 
Epithelial cells from kidney proximal tubules are of the main interest in BAK applications since 
they perform the most in the active reabsorption in the nephron. Active reabsorbtion also includes 
unidirectional transport of uremic toxins described in section 2.2 (Fig. 2.3) [22,23,47]. Moreover, 
proximal tubular cells were reported to perform additional metabolic functions, replacing the other 
physiological functions of kidney. Among such functions are the production of the hormones,  
paracrine factors and cytokines [48–50]. Naturally the cultivation of the cells is performed in 
bioreactor conditions. The bioreactor seeded with the proximal tubular cells is traditionally called 
renal assist device (RAD). 
Overall, using hemofilter with connected in series RAD is intended to mimic the functions and 
the architecture of the nephron (Fig. 2.5). In the following section brief description of the cell types 
used in BAK will be given. Next, the materials and their modifications applied in bioatificial kidney 
will be characterized  
2.5.1. Cell line selection 
Most of the research in bioartificial kidney was performed either on human or animal-derived 
immortalized cell lines or on the primary proximal tubular cells. Early works on BAK were typically 
completed using immortalized Madin-Darby canine kidney (MDCK) cell line [44,51]. Several 
advantages of using immortalized cell lines make them a valuable tool for the research applications. 
Among them is the stability of the cell phenotype, low cost and unlimited proliferative potential. 
Numerous kidney tubular cell lines exist, however only few of them could be used in BAK 
applications. For example, transformed HKC cell line developed in 1997 [52] is used to model 
physiological behavior of tubular cells. However later clones of the cell line fail to form tight 
junctions. Widely used in BAK human transformed proximal tubular cell line HK-2[53] do not 
tolerate of being grown to the confluence [20]. Significant number of works have been performed 
using proximal tubule porcine cell line LLC-PK1 [54,55]. Both MDCK and LLC-PK1 cell lines are 
reported to form confluent functional monolayers and can be grown using simple standard media. 
However, the existing strategy always implies using primary culture of human proximal tubular 
cells (HPTC) in order to confirm the effect obtained for immortal cell lines. Moreover, immortalized 
cell lines, as it was discussed earlier, commonly do not express crucial physiological characteristics 
present in the kidney primary cells. Specifically, for the transport functions of epithelial cells it is 
critical form tight junctions when they are grown in monolayer. 
 
Fig. 2.5. Schematic structure of the nephron [23]. 
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Organic anion transporters, discussed earlier in section 2.2, play critical role in excreting vast 
majority of the toxins from the bloodstream. Specifically, expression of the transporters OAT1, OAT3 
and OAT4 responsible for toxin removal is linked to PDZ (PSD-95, DglA, and ZO-1) binding domain 
proteins, which play role as the scaffolds. In proximal tubular cells these scaffolding proteins are 
thought to generate cell polarity by forming connections with both tight junction complexes and 
transporter proteins and the signaling molecules [47]. Therefore failure to form tight junctions would 
result in impairment of the tubular cell functions. Graphical representation of tight junction 
complexes, scaffolding proteins (ZO-1) and related cell structures is given in following scheme 
(Fig. 2.6). As it could be seen from Fig. 2.6 (b) ZO-1 protein is one of the first adapter molecule that 
connects other scaffolds proteins to the tight junction complex. Therefore ZO-1 protein detection 
became established technique for investigation of the functional properties of proximal tubular 
epithelial cells. 
As it was described above, human and animal-derived, primary and immortalized cell lines are 
used in BAK development. However, it must be mentioned that primary human derived cells must be 
used in clinical trials nowadays. Therefore using primary kidney cells of human origin is the necessary 
step in the development of any renal assist device which is intended to be used in the treatment of the 
patients. Considering all of above, primary cell line of human proximal tubular cells is used in the 
current work. 
2.5.2. Membranes for bioartificial kidney applications 
Considering the contact of BAK membrane with blood, the membranes traditionally used in 
hemodialysis/hemofiltration are involved in these bioreactors development. Consequently these 
membranes are generally of hollow fiber configuration having sufficient properties of their 
hemocompatibility. Despite the diversity of materials used in hemodialysis/hemofiltration, PES/PVP is 
the membrane material of choice in BAK applications and  is used generally as substrate for kidney 
epithelial cells. 
Several requirements must be met for the membranes in BAK applications. As it was already 
mentioned hemocompatibilty is the one of the main prerequisites. In addition to being 
hemocompatible in the layer contacting with blood, membrane surface must bear sufficient 
cytocompatibility on the opposite surface interacting with the cells. Next, sufficient immunoisolation 
of the cell monolayer from the host immune system must be provided. However, at the same time 
membrane transport properties such as flux, fouling stability etc. must be sufficient to allow optimal 
performance of the cells. 
Specifically, blood compatibility (hemocompatibility) of the membranes is the complex process 
involving such possible blood-membrane interactions as hemolysis, clotting, membrane fouling, 
inflammation etc. The membrane properties and material therefore is designed to decrease such 
negative interactions. The choice of PES/PVP materials in BAK becomes evident when its properties 
are considered. The balance of nanoscale hydrophilic and hydrophobic domains on the membrane 
surface is able to provide the optimal hemocompatibility and minimize such processes as clot 
formation or complement activation [57]. Chemical inertness, resistance to oxidation and action of 
free radicals,  thermal and mechanical stability altogether contribute to the selection of PES/PVP 
based materials [25,58,59]. 
 
 
 
 
 
a 
 
 
 
 
 
b 
Fig. 2.6. Schematic representation of cellular junctional complexes [47,56]. 
 
 
 
 13 
Moreover, PES/PVP based membranes provide stable and superior transport properties. 
Established fabrication methods provide asymmetric membrane structures which can be easily tuned 
according to the specific requirements. Polyvinylpyrrolidone (PVP) which is commonly used in 
pharmaceutical applications is added to the PES introduce the membrane hydrophilicity. Addition of 
PVP is reported to contribute to improvement of diffusive properties of the membranes and decrease 
membrane fouling [59–61]. 
One of the specific membrane requirements for the membrane in BAK applications is their 
compatibility to the renal epithelial cells. Therefore the dual task must be performed by these 
membranes. First hydrophilic and antifouling properties are desirable increase blood compatibility and 
protein fouling. And second, ECM proteins are required for adequate cell adhesion and contacts which 
is especially critical when working with sensitive primary tubular epithelial cells. Despite the fact that 
the sufficient number of successful works is already available on immortalized cell lines of animal and 
human origin (e.g. MDCK, LLC-PK1 or HK-2) successful cultivation of primary tubular epithelial 
cells on PES membranes is still limited. In the majority of cases special treatment of the membrane 
surface was required [44,54,62]. Considering the importance of membrane surface modification for 
proliferation of human primary tubular cells this topic is described in the following section. 
2.5.3. Biomimetic surface modification 
Modifications of the polymer surfaces are of great importance in biomedical science and 
research. And the scientific interest to the field is growing continuously. The main aim of the research 
is the engineering of the defined extracellular matrix which would be favorable for cell growth, 
differentiation and proliferation. The need for improving the properties of the carriers is the main 
prerequisite for the majority polymeric and inorganic materials in tissue engineering applications [63]. 
Using the coatings of polycationic synthetic peptide poly-L-lysine was among the first 
successful strategies to obtain cytocompatible films on the wide range of surfaces. Other polycations 
such as polyornithine, chitosan etc. can also be used to improve surface biocompatibility, however 
poly-L-lysine based coating comprise the majority of early works on this topic. Among the examples 
of such applications could be the work of Orłowski et al [64] for pancreatic cells immunoisolation 
within alginate membrane. Biocompatibility of alginate/poly-L-lysine system is reviewed in the much 
later work of Orive et al. in  2006 [65], showing the strong scientific interests to this strategy. 
Simplicity, ease of us and effectiveness of poly-L-lysine coatings made it the material of choice for 
many biological applications and for the routine procedures in animal culture labs worldwide [66]. 
However, pro inflammatory effects of the coating, restricts the use of the compound for in vivo 
applications or require additional modifications of the coatings by using such glycosaminoglycan as 
heparin [67]. 
Another widely applied strategy for creating biocompatible, biomimetic surfaces for wide range 
of animal cell applications emerged shortly after discovery of integrins and their physiological ligands 
[68]. Integrins (Fig. 2.7) comprise a large family of heterodimeric glycoprotein receptors that play 
major roles in cell to ECM adhesion, cytoskeleton organization, intracellular signaling etc. [23,69]. 
 
 
Fig. 2.7. Schematic representation of an integrin receptor [23]. 
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Different types of integrins exhibit various degrees of binding to such extracellular matrix 
components as collagens,  fibronectins,  laminins, and cellular receptors such as vascular cell adhesion 
molecule-1. However, it was discovered that the RGD sequence (standing for tripeptide composed of 
L-arginine, glycine, and L-aspartic acid) was largely responsible for integrin binding activity in  
various natural and synthetic compounds that could be used in cell culture applications to improve cell 
adhesion and promote cell differentiation and proliferation [68–70]. 
Consequently, the use of natural or synthetic RGD – containing ligands became the most 
accepted strategy, especially when functionally attached, polarized cell structures are required. 
Specifically, use of collagen-derived RGD peptides was reported by Jeschke et al. [70] to improve 
significantly monolayer formation of the chondrocyte cell line.  
Taking into account cell type specificity of integrin expression, various coatings were developed 
to meet the requirements for the particular application. Special attention in the recent years was paid 
for multilayer coatings using layer-by-layer assembly of polycations and polyanions. Numerous 
polyelectrolytes could be used in the technique according to the specific goals needed to be achieved. 
One of the main advantages is the stability of the layer and fine-tuning of the surface properties by 
varying the number of the layers and their sturcture [70–73]. 
Collagen – hyaluronic acid multilayers were reported by Zhang et al. [72]  to facilitate 
chondrosarcoma cell line adhesion and proliferation. Combination of collagen and chondroitin sulfate 
coatings were known to be used in osteoblast cell culturing. Biomimetic coating  of collagen type I 
and chondroitin sulfate, as it was reported by Vandrovcová et al. [74], improved MG 63 cell adhesion, 
proliferation and differentiation on on poly-(lactide-co-glycolide) polymer surface. Especially 
promising application of to the multilayer systems is in cultivation of stem cells or muscle cells which 
are sensitive to the surface stiffness. Richert et al. [75] described in their work the possibility of 
optimizing the coatings for smooth muscle cell cultivation. Authors exploited fine tuning the 
properties of poly-L-lysine / hyaluronic acid coatings by changing film thickness and cross-linking 
ratio and collagen addition.  Use of collagen coatings was widely reported for hepatic cell cultivation. 
In the recent work of [76], authors showed important role of collagen type IV in pancreatic cancer cell 
proliferation, migration. Use of collagen in engineered systems of hepatic cells for bioartificial liver 
applications are reported extensively [63,77,78]. 
Yet another promising strategy for biomimetic coating was introduced by Messersmith research 
group upon their discovery and publication in Science of their milestone article on mussel-inspired 
coating of polydopamine in 2007 [79]. The large attention received by the topic of mussel-inspired 
coatings could be explained by its numerous advantages. First, simple immersion of various substrates 
in the slightly basic solution of L-DOPA (Fig. 2.8.) results in oxidative self-polymerization and 
deposition of adherent polymer film. Second, film thickness can be varied from few to hundred 
nanometers depending on the coating conditions. Next, a distinctive property of the polydopamine 
film, is its ability to deposit on the vast variety of the organic materials including non-wetting polymer 
surfaces such as polyethylene, polytetrafluorethylene, polydimethyl-siloxane etc. Inorganic surfaces 
such as noble metals, metals, metal oxides, mica, silica, ceramics etc. are also reported to be 
successfully coated with polydopamine. The investigation of the mechanism of spontaneous L-DOPA 
polymerization and the surface adhesion is still in its progress. Role of cathecholic group is thought to 
be crucial in the adhesive mechanism since concentrations of L-DOPA, dopamine and the other 
catecholic units prevail in naturally occurring mussel adhesive proteins. Specifically, it is agreed that 
complexating of TiO2 nanoparticles with polydopamine involves chelating mechanism with the 
deprotonation of hydroxyl groups of the catechol molecule as an example. Moreover all catechol 
molecules readily establish strong non-covalent or covalent interactions with organic substances 
involving p-electron, hydrogen bonding and Michael interactions. The latter, Michael or nucleophilic 
interactions will be discussed later in this chapter when describing poly-L-DOPA layer 
functionalization step [79–83]. 
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Single poly-L-DOPA or polydopamine coatings are reported to improve and fine tune surface 
properties to meet the requirements needed for industrial, biomedical or tissue engineering 
applications. First, poly-L-DOPA layers are known to increase hydrophilization of the surface. The 
presence of two full charges within the single poly-L-DOPA structure unit is responsible for the effect. 
Positive and negative charges of cyclo-dopa (Fig. 2.9) establish ionic-dipole interactions with water 
molecules. Therefore, properties of single poly-L-DOPA coatings are used to obtain anti-fouling 
membrane surfaces, absorb toxic substances from bulk solutions, fine tune the pore size, scavenge free 
radicals etc. [82,84]. 
Use of the coating of the poly-L-DOPA in the current work for creating bioinspired layer was 
largely influenced by the cytocompatible properties of the substance and by the ease performing the 
secondary reactions to create ad-layers to provide desirable functions. Specifically, coating along was 
shown to promote the proliferative and adhesive  behavior of mammalian cells on the example of 
fibroblast cells [79]. However, the full potential of poly-L-DOPA coatings can be estimated when its 
functionalization is considered. 
The modification of poly-L-DOPA layer is possible through various mechanisms. Particularly 
in the case of proteins catecholic groups and the products of their oxidation – o-quinones exhibit 
strong reactivity towards nucleophilic side chain amino acid residues present in peptide chain. 
Formation of Schiff bases or Michael adducts is reported when reacting mainly with amine and thiol 
groups of proteins. In this manner, covalent bonding of poly-L-DOPA layer to nucleophiles is thought 
to be one of the main mechanisms of proteins bioconjugation onto the coating layer. Moreover, such 
weaker interactions as π-electron delocalization in aryl groups of the molecules, van der Waals forces 
and hydrogen bonding additionally stabilize the formed double layer [81,82,85].  
When protein bioconjugation is considered, special attention must be paid for the preservation 
of protein native configuration. Promising results were reported when attaching various proteins onto 
poly-L-DOPA layers. Specifically, Rivera and Messersmith [85] showed in their work 5 to 8- fold 
increase of enzymatic activity of trypsin when immobilized on polydopamine layer compared to silica 
or titania monolithic supports. Conjugation of hyaluronic acid was shown by Lee at al. [79] to promote 
megakaryocytes adhesion. Poh et al. [86] reported immobilization of vascular endothelial growth 
factor onto the polydopamine film without losing the activity of the protein. Which in turn, promoted 
human dermal microvascular endothelial cells attachment, viability and proliferation compared to the 
 
Fig. 2.8. Structural formula of L-3,4-dihydroxyphenylalanine or L-DOPA. 
 
 
Fig. 2.9. Proposed mechanism of L-DOPA oxidative self-polymerization [84]. 
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unmodified substrate. The osteogenetic differentiation  in BRE-Luc C2C12 myoblast stem cells was 
reported by Kang et al [87] when using L-DOPA assisted bone morphogenic protein conjugation onto 
titania surface. 
Coatings of extracellular matrix have been used extensively by various researchers to improve 
the performance of renal cells for bioartificial kidney applications. Humes et al. [44] in early 1998 in 
their pioneering work initiated the strategy for applying biomimetic coatings for renal assist devices 
(RAD). In their research authors coated polyethersulfone hollow fiber membranes with synthetic 
RGD-containing protein pronectin-L to facilitate the performance of porcine primary renal proximal 
tubular cells. Since then, various approaches have been applied to provide sufficient 
immunoprotection, cell compatibility and the transport properties of the membranes. However, 
extensive analysis of the extracellular matrix coating on the performance of human renal cells is still 
missing. 
The attempt of such systematic analysis was performed in the research by Zhang et al. [88]. The 
impact of extracellular matrix coatings on the performance of immortalized human renal cell line HK-
2 and primary human proximal tubular cells (HPTC) applied in bioartificial kidneys was investigated 
in the work. Various coatings of defined composition including such components and the mixtures of 
ECM as collagen type I , gelatin, collagen type IV, laminin, nidogen, nephronectin, Poly-D-lysine etc 
were studied. Moreover, effect of using Matrigel – complex mixture of ECM proteins was also 
investigated. The most promising results were obtained for the coatings consisting of such components 
of the basal lamina as laminin or collagen IV. Differentiated monolayers of HK-2 and human renal 
proximal tubular cells were obtained for the specified coatings. However, it must be mentioned that 
the authors performed their study working with flat, dense surfaces of standard tissue culture 
polystyrene 24-well plates. Therefore, additional improvement of the coating architecture is required 
when working with porous hollow fiber polymer surface. 
Taking into account all of above using of double coatings of poly-L-DOPA combined with 
RGD-containing components of the basal membrane could be extremely promising approach. 
Specifically, this approach was investigated in the work of Ni et al. [54] where the authors tested 
different membrane materials used in hemodialysis/hemofiltration and coatings as described above. 
Numerous challenges of the approach arose with using the membranes instead of polystyrene tissue 
culture plates. Among those were the properties of the bulk materials such as contact angle, surface 
charge etc, as well as such the properties of the membrane itself such as pore size or membrane 
roughness. All these factors could play detrimental roles both for applying the coating and for the cell 
attachment. Authors tested two cell types, immortalized renal cells HK-2 and primary human  renal 
proximal tubular cells. The cell performance was evaluated on native, L-DOPA coated, and L-DOPA 
+ collagen IV coated flat sheet membranes. From the results it can be concluded, that PES/PVP 
membranes performed the most efficiently compared to the other materials used in hemodialysis 
application in sustaining renal cell lines. HK-2 cells formed distinctively differentiated and polarized 
epithelium with clear tight junction formation after 7 days of culturing on PES/PVP L-DOPA coated 
membranes (Fig. 2.10 a). However, it must be mentioned that the clinical importance of HK-2 cell line 
is low, therefore human primary cell line experiments are required. As it was shown, in the later 
studies, human renal proximal tubular cells were not able to proliferate efficiently on native or L-
DOPA coated membranes, implying the more demanding nature of the cells for the conditions of their 
cultivation (Fig. 2.10 b). However some level of tight junction formation and differentiation was 
obtained by the authors for polysulfone/polyvinylpyrrolidone (PSF/PVP) membrane double coated 
with L-DOPA and collagen type IV (Fig. 2.10 c). 
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As it can be seen from above, special attention  should be paid towards selection of the 
membrane materials and their coatings. In the current work, the performance of primary culture of 
human renal proximal tubular cells is described. In addition to the demanding nature of these cells to 
the ECM conditions and growth factors, outer surface of  hollow fiber membranes is chosen as 
substrate for cell proliferation. Thereby, new parameters such as  membrane curvature and the absence 
of passive, gravity facilitated attachment, as in case with flat membranes, are to be considered. 
 
 a   b  c 
Fig. 2.10. Immunostaining for tight junction ZO-1 protein (green) of renal cells after one week 
incubation on coated  flat synthetic membranes: a – HK-2 cells on PES/PVP flat L-DOPA coated 
membrane; b – HPTC on L-DOPA coated PES/PVP membrane; c – HPTC on double coated with L-
DOPA and collagen IV PSF/PVP membrane [54]. 
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3. MATERIALS AND METHODS 
3.1. Reagents, materials and the supplies 
• Two types of commercial PES based membranes were used in the experiments. 
PES/PVP/PA-based HCO 1100® HD hollow fiber membrane of ultrafiltration range 
were obtained from Theralite™ hemodialyzer (Gambro, Dialysatoren GmbH, 
Hechingen, Germany). Also, PES/PVP microfiltration range apheresis membranes 
MicroPES® TF10 were purchased from Membrana GmbH, Germany (Appendices C, D 
and E). 
• Polyethylene tubes (Rubber BV, Hilversum, The Netherlands) of 6 mm in outer 
diameter were used as housing for assembly of the mini-modules. Festo push-in T-
connections (Brussel, Belgium) or Kartell® polypropylene T-shaped tubing connectors 
(Kartell, Milan, Italy) were used to provide 4-port architecture of the modules. Two 
component polyurethane potting (Intercol B.V., Ede, The Netherlands) was applied for 
potting of the modules (Appendix E). 
• Ultrapure water was used for preparing of the solutions, buffers and pure water flux 
(PWF) experiments unless stated otherwise. All ultrapure water was obtained from a 
Mili-Q Advantage A10 purifications system (Millipore, Billerica, USA) having 18 MΩ 
at 25 ºC. 
• All chemicals used in the work were of analytical or cell culture grade, used as received 
and stored at 4 ºC in the fridge unless stated otherwise. Bovine serum albumin (BSA), 
3,4-Dihydroxyphenylanine (L-DOPA) ,Tris(hydroxymethyl)aminomethane (Tris), 
immunoglobulin G (IgG), human collagen type IV  were purchased from Sigma-Aldrich 
(St. Louis, MO, USA). 
• Nitrocellulose 0.2 μ Millex® syringe filters were used for filter-sterilization and 
providing gas exchange in batch bioreactors (Millipore, Billerica, USA). 
• The culture of human renal proximal tubular epithelial cells (HRPTEPIC or in short 
HTPC ) used in the experiments, was obtained from ScienCell Research Laboratories, 
Carlsbad, USA. The cells were supplied in dry ice and stored in liquid nitrogen for 
cryopreservation. Cell culture was handled and maintained according to the 
recommendation of the supplier [89]. 
• Primay polyclonal rabbit anti-ZO-1 antibody was purchased from Invitrogen (Life 
Technologies,Carlsbad, USA). Alexa Fluor® 488 Goat Anti-Rabbit IgG secondary 
antibody and DAPI were purchased from Molecular Probes®-Invitrogen (Life 
Technologies,Carlsbad, USA).  
• Clonetics™ renal epithelial basal medium (REBM) and REGM™ BulletKit™ 
supplements were purchased from Lonza, Basel, Switzerland. Supplements were 
shipped in dry ice and stored at -20 ºC according to the manufacturer’s instructions [90]. 
• Trypsin-EDTA solution, PBS tablets, sterile HBSS  supplemented with Ca2+/Mg2+ and 
calcium and magnesium free DPBS were obtained from Gibco® (Life 
Technologies,Carlsbad, USA). 
• In current work the following buffer solutions were used. Phosphate buffered saline 
(PBS), with pH=7.4 was prepared by dissolving the tablets according to the 
manufacturers instruction.10mM Tris-HCl buffer was prepared by dissolving TRIS in 
ultrapure water, and adjusting pH to the value of 8.5 with 1N HCl / 2N NaOH. Such 
sterile buffer solutions as DPBS, HBSS were used as supplied. 
• Other used chemicals were of analytical grade and used without further purification. 
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3.2. Assembly of the mini-modules 
Mini-modules prepared consisted of from 1 to 3 hollow fibers in polypropylene housing. To 
prepare the modules hollow fiber membranes were first cut to a length of 20 cm. Both ends of the 
hollow fibers were glued to secure the lumens of the membranes. Polypropylene housing (6 mm outer 
diameter, 4 mm inner diameter) was cut to the length of 8.5 cm, T-shaped connectors were fitted to the 
both ends of the housing. Smaller pieces of housing of 5 cm were fitted into the connectors and the 
membrane fibers introduced into the mini modules. Housings of 3 cm were introduced in the lumen 
ports of the modules.  
Two type of connectors were used in the current work. Reusable Festo push-in T-connections 
were chosen for the modules for the membrane transport testing. Whereas, dispensable Kartell® 
polypropylene T-shaped tubing connectors selected for the cell culture experiments. 
After having inserted hollow fibers into the modules, potting process started. Two component 
potting was used. After mixing the components of the potting Pur N and Pur 150 in a ratio of 100:150, 
then glue was allowed to cure for 3.5 to 4 hours to reach the gel consistency. Outer ends of the 
modules on the one side were filled with glue with a syringe to occupy the space between the entrance 
and  the connectors, thereby reducing the volume of the dead ends. Glued outlets were sealed with 
parafilm, to prevent the leaking of the glue out. Modules were kept vertically with the glued end 
facing downwards for at least 24 h for hardening. The similar potting procedure was performed for the 
opposite ends of the modules. Active length of the fibers in the modules prepared as described was 
equal approximately 11 cm, and the exact value was obtained after the modules were disassembled 
and the fiber lengths were measured. After potting the ends of the modules were cut open. Images of 
the prepared modules are given in Appendix E. 
3.3. Modification of PES-based hollow fiber membranes 
Interfacial self-polymerization of dopamine was performed by exposure of the outer surface of 
the hollow fibers to the dopamine solution. To prepare the solution, L-DOPA was dissolved in  10 mM 
Tris-HCl buffer, pH=8.5, with the final concentration of 2 g/L of L-DOPA. Solution was kept open to 
atmospheric oxygen at 37 ºC to induce the self-polymerization process for 1 hour and stirred with a 
magnetic stirrer (190 rpm). After preparing the solution, filtration with 0.2 μ filter was performed and 
dynamic coating of the hollow fibers with poly-L-DOPA was applied using a multi-channel cartridge 
peristaltic pump 205U (Watson-Marlow, Wilmington, USA). Prior to coating, after installing the 
modules into the hydraulic circuit, modules were washed with ultrapure water for 30 min, emptied and 
equilibrated with Tris-HCL buffer for 30 min at the flow rate 0.8 ml/min and emptied again. 
Afterwards, coating with p solution was performed at the same flow rate at 37 ºC for 2 hours. Next, 
modules were emptied, and dried for 15 min with following washing with ultrapure water for 30 min. 
After the coating was performed modules were kept wet at 4ºC before using for the maximum duration 
of 24 hours. When coating the modules for the cell culture experiments, the system and modules were 
sterilized with 70% EtOH before starting coating process. After ethanol sterilization, 0.2 μ filters were 
installed in the inlets of the modules to ensure sterile conditions, and the coating was performed as 
described above. 
Double coating with human collagen type IV (Col IV) was applied on the poly-L-DOPA coated 
membranes according to the literature with some modifications [88,91,92]. Single coated membranes 
were equilibrated with DPBS before the double coating for 30 min.  Amount of 1 ml of Col IV 
solution diluted in DPBS to concentration 25 μg/ml was injected in the lumen of the modules with a 
syringe in sterile conditions under LFH and the outlets of the modules were secured with the end cap 
(Festo, Brussel, Belgium). Thereafter, modules were incubated for 1 h at 37 ºC, with the rotation of the 
modules at 180º after half an hour. After 1 h of the Col IV coating solution was aspirated and the 
modules were dried overnight at 37 ºC in the incubator. Before using in cell culture experiments, the 
membranes were equilibrated with HBSS for 30 min. Ultrapure water was used for equilibration 
before performing PWF tests and PBS was used for protein permeation experiments. 
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3.4. Hollow fiber membranes characterization 
3.4.1. Hydraulic permeability experiments 
To perform dynamic characterization of hollow fibers performance and to investigate the effect 
of coatings on the membranes permeation tests were performed. Membrane transport measurements 
were performed using lab-scale Kross Flo Research IIi system (Spectrumlabs, Houston, USA) and a 
back pressure valve (KrosFlo® Automatic Backpressure Valve, Spectrumlabs, Houston, USA) were 
used to provide constant transmembrane pressure during the experiments. 
For all permeation experiments membranes were wetted in ultrapure water for at least 2 hours at 
room temperature. Mini-modules were tested in Kross Flo setup in hemofiltration mode, when fluid 
was fed in the lumen inlet, retentate was collected from lumen outlet port and permeate was collected 
from the shell side outlet. Transmembrane pressure (TMP) was regulated using a back pressure valve 
by pressurizing the retentate stream, and permeate stream was at the atmospheric pressure. 
After filling the hydraulic system with water in all streams and equilibrating for 30 min with no 
TMP applied, TMP of 0.25 bar was used to pre compress the membranes. Afterwards, the permeate 
flux was measured for subsequently applied pressures of 0.1, 0.15 and 0.2 bar for at least 15 min for 
each pressure in the steady state conditions. Mass of the permeate was collected with a digital 
laboratory balance for each time interval. Density of water was assumed to be equal 1 g/cm3 to relate 
mass and volumetric fluxes. Hydraulic permeability of the membrane Lp was calculated using Darcy’s 
Law [58,93] : 
𝐽𝑣 =
𝑉
𝐴 ∙ ∆𝑡
= 𝐿𝑝 ∙ 𝑇𝑀𝑃 (3.1) 
Where: 
V – volume of permeate; 
A – membrane area; 
Lp – hydraulic permeability; 
TMP – transmembrane pressure; 
Jv – permeate volumetric flux. 
 
Permeate flux data were calculated with Eq. 3.1 and plotted as a function of TMP. After 
performing linear regression, membrane hydraulic permeability in L/m2/h/mbar was obtained from a 
slope of the linear function. 
3.4.2. Protein permeation and apparent sieving coefficient determination 
Protein solutions in PBS were used in all permeation experiments. Transport of two model 
solutes was investigated. First, permeation of bovine serum albumin (BSA) in PBS of concentration 1 
mg/ml was assumed to model behavior of albumin in hemofiltration in patients. Second, the transport 
of immunoglobulin G (IgG), the main circulating antibody in humans was investigated. Concentration 
of IgG in  model solution was equal to 0.02 mg/ml. Protein permeation was investigated similarly to 
the method described in 3.4.1 using Eq. 3.1. with several modifications. Before protein permeation, 
the membranes were equilibrated with PBS for 30 min. Thereafter, modules were emptied and protein 
solution was fed to the lumen side of the modules without applying external TMP. After the filling of 
all hydraulic system with liquids, permeation started for the previously used set of TMP, 0.1, 0.15 and 
0.2 bar. After obtaining steady state conditions for each pressure (15 – 20 min) permeate was collected 
and the weight of it was recorded with a digital laboratory balance for at least 15 min. 
Membrane transport properties are commonly described in terms of solute retention and solutes 
and solvent flux [94]. Describing retention of solute in terms of sieving coefficients are often used. 
Apparent (observed) sieving coefficient So is a fraction of solute that passes through the membrane 
into permeate stream from feed stream, which could be calculated using following equation [95]: 
𝑆𝑜 =
𝐶𝑝𝑒𝑟𝑚
𝐶𝑓𝑒𝑒𝑑
 (3.2) 
Where: 
So – apparent sieving coefficient; 
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Cperm – protein concentration in the permeate; 
Cfeed – protein concentration in the feed. 
 
Samples from the feed and permeate streams were taken for each TMP value, and protein 
concentrations were determined spectrophotometrically using (Varian, Cary 300 Scan UV–visible 
spectrophotometer (Varian, Inc.,Palo Alto, USA) at the wavelength 280 nm. 
3.4.3. Scanning electron microscopy 
Surface morphology of hollow fiber membranes were imaged by field emitting FEI 
environmental scanning electron microscope XL30 ESEM (FEI, Eindhoven, The Netherlands). Cross 
sections of the fibers with clear, straight edges were obtained by freeze fracturing in liquid nitrogen. 
Hollow fiber samples for the side surface investigation as well as the cross-section samples were dried 
at 37 ºC overnight after placing them onto sample holders. After drying the samples were gold 
sputtered using a BalzersUnion SCD 040 sputter coater (Oerlikon Balzers, Balzers, Liechtenstein) and 
imaged with the electron microscope. 
3.4.4. Coating characterization by ATR-FTIR 
Differences in chemical composition of unmodified and coated membranes were investigated 
using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR, PerkinElmer, 
Waltham, USA). Changes in the composition of various functional groups were compared between the 
spectra of unmodified, L-DOPA coated and L-DOPA + Col IV double coated hollow fibers. 
3.5. Cell culture in vitro 
Primary renal proximal tubular epithelial cells [89] obtained from ScienCell Research 
Laboratories, Carlsbad, USA, were cultured in renal epithelial basal medium supplemented with  
Media Clonetics™ REGM™ BulletKit™ containing 0.5% fetal bovine serum, 0.5 ml of Human 
Epidermal Growth Factor (hEGF), 0.5 of ml hydrocortisone, 0.5 ml of epinephrine, 0.5 ml of insulin, 
0.5 ml of triiodothyronine, 0.5 ml of triiodothyronine, 0.5 ml of transferrin and of 0.5 ml of gentamicin 
sulfate/amphotericin-B (GA). Culture and subculture of the cell line were carried out according to the 
supplier recommendations and the data available from literature [20,54,66,89]. Unless stated 
otherwise, all cells were propagated using standard tissue culture polystyrene plastic, handled in 
aseptic conditions in the laminar fume hood (LFH) and inculbated at 37 ºC in humidified atmosphere 
with 5% CO2. Cell counting was performed using Neubauer hemacytometer chamber (Laboroptic Ltd, 
Lancing, United Kingdom). Cells used in all experiments were of the passages up to V. 
3.5.1. Initiating the culture 
Cryopreserved cells were used for culture initiation. Vials were thawed in a 37 ºC water bath 
and seeded immediately in the cell culture flask with 5 ml of pre warmed complete renal epithelial 
growth medium (REGM). Poly-L-lysine (2μg/cm2) coated T-25 culture vessel was used for culture 
initiation. Seeding density of 10 000 cells/cm2 was used. Afterwards, after closing the cap of the 
vessel, flask was gently rocked to distribute cell even and propagated in the incubator after loosening 
the cap for the gas exchange. On the next day, media was refreshed to remove residual DMSO from 
the culture medium. Media refreshment was performed on each 3 days of the culturing or earlier if 
indicated by the drop of pH reflected in the significant color change of the medium. Cells were 
cultured until 80 % confluence. 
3.5.2. Subculturing 
Upon reaching 80 % confluency cells were trypsinized and passaged. Culture medium, DPBS 
and trypsin solution were pre warmed in a water bath at 37 ºC. After aspirating the medium from cell 
culture flasks cells were washed with DPBS and the trypsin solution was added to the flasks and 
placed for 2 min in the incubator. Cell detachment was inspected in the inverted microscope. Instantly, 
culture medium was added to the flask to block the action of trypsin, cell suspension was transferred in 
the centrifuge tube and centrifuged for 5 minutes at 300 RCF. After centrifugation, supernatant was 
aspirated and cells were resuspended with the culture medium to the given concentration. Cell 
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counting was performed using hemacytometer chamber according to the manufacturer instructions 
[96]. Fluorescent stained cell nuclei were counted using the 100 × 100 𝜇𝑚  grid provided by the 
microscope software. Cells were seeded in the flasks at the density of ~ 5000 cells/cm2. After the 
seeding the flasks were incubated at 37 ºC in humidified atmosphere with 5% CO2. Refreshing of the 
media was done on the third day of the culture or when indicated by the color change of phenol red pH 
indicator. Subcultures of cells used in all experiments were of 80% confluency or less. Evaluating of 
the cell growth rate was performed by calculating population doubling time using the following 
equations [97]: 
𝑥 = 𝑥0 ∙ 𝑒𝜇∙𝑡 
 
 
𝑡𝑑 =
ln (2)
𝜇
 
(3.3 a) 
 
 
 
(3.3 b) 
Where: 
xo – initial cell density; 
x – cell density at time t; 
μ – specific growth rate; 
td – doubling time. 
 
Characterization of cell morphology was done using inverted light microscope or EVOS® FL 
fluorescent microscope (Life Technologies, Carlsbad, USA). Amounts of the DPBS, trypsin and 
culture medium used for cell maintenance are listed in Table 3.1. 
Table 3.1. Cell subculture parameters 
Cell culture 
flask 
Maintenance 
medium (REGM), ml 
DPBS washing, 
ml 
Trypsin solution, 
ml 
Trypsin blocking 
solution (REGM), 
ml 
T25 5 5 1.5 5 
T75 15 10 3 10 
T175 30 15 5 15 
 
3.6. Bioreactor conditions 
HCO  1100 and MicroPES TF10 membranes were used to serve as cell scaffold in semi batch type 
membrane bioreactor. The membrane area available to the cells in the mini-modules was estimated as 
~1 cm2. Before the cell seeding modules were treated with 70% EtOH for 30 min for sterilization and 
coated as described in 3.3. Coated membranes and control samples were afterwards washed with 
HBSS 3 times for 10 min. Afterwards, cells were trypsinized and cell suspensions with 5∙105 cells was 
seeded into each of the modules. Outlets of the modules from the shell side were secured with the 
syringe filters, lumen outlets with push-in caps. Thereafter modules were placed in the incubator at 37 
ºC for cell attachment for 1 hour, with the rotation on 180º after 30 min. Conditionally, to facilitate 
cell adhesion, the negative pressure was applied in the shell side by suction the fluid from the lumen of 
the fibers with a syringe for a short period of time. Upon module rotation after 30 min, the procedure 
was repeated. After 1 hour, cell suspension was removed from the modules and replaced with equal 
amount of culture medium. Modules were placed statically in the incubator, with media refreshment 
and 180º rotation each 24 hours. 
 
3.6. Direct and indirect fluorescent staining 
To investigate cell properties, morphology and the viable cells density fluorescent staining 
techniques were performed to the cells attached to the hollow fiber membranes. In all experiments, 
after modules disassembly membranes were washed with HBSS and fixed in the solution of 2 % 
paraformaldehyde and 4% sucrose  in HBSS for 5 min.  
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Indirect immunostaining for zonula occludens protein-1 was performed to investigate cell 
polarization and monolayer confluency. After fixating membranes were washed for 5 min in 4% FBS 
in HBSS. Thereafter, cells were permeabilized with 0.3% Triton solution in HBSS. Permeabilized 
cells were incubated in block solution for 30 min which consisted of 2% of BSA, 2% of FBS and 0.1% 
of Tween20 in HBSS. The described block solution was also used to prepare dilutions of primary and 
secondary antibodies. After blocking, the solution of primary polyclonal rabbit anty-ZO-1 antibody of 
concentration 5 μg/ml in block solution was applied and the samples were kept overnight in the fridge 
at 4ºC. Subsequently, the cells were washed with 4% FBS in HBSS 3 times for 10 min and secondary 
Alexa Fluor® 488 goat anti-rabbit IgG, diluted to the concentration 10μg/ml in block solution (1:200 
dilution) was applied on the samples for 30 minutes at the room temperature in the dark environment. 
After binding of the secondary antibodies the samples were washed with 4% FBS in HBSS 3 times for 
10 min. 
Direct immunofluorescence technique with fluorescent DNA-binding molecule -  DAPI was 
applied to estimate cell density and viability. Pre washed with HBSS samples were used for the 
staining. DAPI diluted in HBSS to the 300 nM concentration was applied onto the samples for 10 min. 
Thereafter samples were washed with HBSS 3 times for 10 min, and kept in the dark environment. 
 
3.7. Attachment of cells to hollow fiber membranes 
Adherence of the cells to membrane scaffolds was investigated using DAPI staining technique, 
described previously in 3.6., and cell detachment with trypsin. Following the disassembly of the 
modules, hollow fiber membranes of defined lengths were washed with DPBS and placed in 0.5 ml of 
trypsin solution. Cells were incubated for 10 min at 37 ºC to perform trypsinization and 1.5 ml of 
culture medium was added to inactivate action of the enzyme. After centrifugation at 5000 RCF and 
aspirating of supernatant, cells were resuspended in 0.1 ml of culture medium. 
3.8. Cell imaging 
After fluorescent staining, samples were imaged using epifluorescent EVOS® FL fluorescent 
microscope (Life Technologies, Carlsbad, USA) or laser confocal microscope (Zeiss LSM 510, Carl 
Zeiss AG, Oberkochen, Germany). Inverted light microscope was used for cell density and 
morphology observation during subculturing. 
3.9 Statistical analysis 
Raw data calculation and processing and imaging were done with Microsoft® Excel (Microsoft 
Corp., Redmond, USA) and OriginPro (OriginLab® Corp., Northampton, USA). Statistical analysis 
was performed using OriginPro software. First, the data sets were evaluated for containing the outliers 
with Grubb’s test. Consequently, the difference between the groups was detected by comparing the 
group means using Student’s t-test. Significance level of 0.05 was used for the analysis. 
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4. RESULTS AND DISCUSSION 
In this chapter, two types of commercial membranes were characterized and examined on their 
ability to serve as the scaffolds for the human primary kidney cell culture. First, membrane surface 
topography, roughness, pore size, etc., were investigated with scanning electron microscopy. Effect of 
coatings and membrane transport properties were examined using such dynamic characterization 
techniques as pure water and protein permeation tests. And finally, cell culture experiments were 
performed. 
4.1. Surface characterization of hollow fiber membranes 
Surface topography is one of the most important parameters for the successful cell attachment 
and proliferation. Both membranes, HCO 1100 and MicroPES TF10 were used in clinical practice for 
blood and plasma separation applications and have excellent hemo- and cytocompatibility 
[35,59,98,99]. 
SEM images of the polyethersulfone based HCO 1100 and MicroPES TF10 membranes are 
shown in Figs. 4.1 and 4.2 respectively. From images it can be established that HCO 1100 membrane 
is characterized by the typical asymmetric structure. It can be clearly seen  in the Figs. 4.1 a-f, that 
HCO membranes possess a dense selective skin layer in the lumen side of the fiber. Finger-type 
macrovoids are present in the membrane support layer, and sponge-type structures with the smaller 
pores underlie the polyamide skin selective layer of the lumen side. 
MicroPES membranes, on the contrary, did not contain macrovoids or microporous selective 
skin layer.  Sponge-like structure was present throughout the whole length of the membrane wall. As 
shown in Fig 4.2 pore size distribution of the MicroPES membrane is more narrow compared to HCO 
1100 membrane. Macropores of the size ~0.1 – 0.5 μ are present on both skin and shell surface of 
hollow fibers. Comparing the lateral surface morphology of the membranes at high magnifications 
(Fig. 4.1 (c) and 4.2 (c) it can be seen that MicroPES TF10 membrane has increased roughness 
compared to HCO 1100 membrane, whereas the later, possess smooth outer surface. Also it can be 
concluded that HCO 1100 membrane has larger macropores or wide distribution on its outer surface 
a b c 
d e f 
Fig. 4.1. Scanning electron microscopy images of lateral surface (a, b, c) and the cross sections (d, e, f) 
of HCO 1100 hollow fiber membranes. 
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whereas, as it was already mentioned macropores of MicroPES TF10 membrane are the of more 
uniform size. 
The obtained results reflect the data present in literature and correspond to the application fields 
of the both membranes. Thus, HCO membrane was designed to achieve permeability of the middle 
molecules of molecular weight 15 – 45 kDa [100] and provide adequate retention of the large 
molecules such as albumin (67 kDa) in haemofiltration treatment. Moreover, since the membrane is 
used clinically for HD therapy, it should minimally interact with plasma proteins to reduce membrane 
fouling to provide stable membrane permeability during the treatment of the patients. According to 
Ronco et al. [59] such three-layer structure optimizes the transport and permeability properties of the 
membrane. 
On the contrary, plasma separation MicroPES TF10 membranes were designed to allow the 
passage of all blood protein and to retain the blood cells. Membranes nominal pore size was equal to 
0.2 μ (Appendix D) which is correlated to the size of the human cells. At the same time, protein open, 
microfiltration type structure of MicroPES TF10 membrane would imply the risk of the membrane 
fouling due to pore plugging [101]. But again, taking into account that the membrane initially was 
designed to be used in plasma separation applications, which normally run in the batch mode, this 
effect might not impact significantly overall efficiency of the process. Moreover, since in the current 
work MicroPES TF10 membrane is intended to be used as a cell scaffold, these properties could have 
positive overall effect on the membrane performance. First, the size of the pores is uniformised to 
retain and concentrate the blood cells for the further use. And second, having a monolayer of cells on 
the hollow fiber surface would decrease dramatically convective properties of the membrane, which in 
turn would alter pore plugging with proteins [99,98,102]. 
Overall, it could be concluded from the obtained microphotographs and the literature data that 
according to their pore size the two membranes can be classified into ultrafiltration and microfiltration 
types. Pore size of MicroPES TF10 membranes is adjusted to the size of human cells. However, the 
surface of MicroPES TF10 membranes possesses roughness in the nano scale, which could increase or 
decrease cells attachment and proliferation when comparing to HCO 1100 membrane, which should be 
further investigated. 
a b c 
d e f 
Fig. 4.2. Scanning electron microscopy images of lateral surface (a, b, c) and the cross sections (d, e, f) 
of MicroPES hollow fiber membranes. 
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It must be also mentioned, that no difference in SEM microphotographs was observed for the 
membranes coated according to the procedure described in the section 3.3. Apparently, more sensitive 
technique is required to detect the nanoscale changes in membrane structure. Therefore such attempt 
was performed using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-
FTIR). Transmittance spectra of coated and virgin HCO 1100 and MicroPES TF10 membranes are 
given in Figs.  4.3 a and 4.3 b respectively. 
It can be seen from the graphs that no significant differences is observed. In fact, when analyzed 
with Spectrum for Windows software, spectra 1-3, within the same membrane type showed more than 
99% similarity and no separate distinctive peaks can be observed in the modified membranes 
compared to the native one. Despite the fact that, L-DOPA coating on the surface of the hollow fibers 
was visually observed (Appendix E) chemical group analysis did not vary significantly. 
When comparing the results with the data present in literature, it becomes clear that the spectra 
provided for polydopamine or poly-L-DOPA coatings were obtained from the flat membrane samples 
coated for at least 24 h in static conditions [103,104]. Therefore, the obtained results signify that layer 
thickness of poly-L-DOPA deposited in the dynamic conditions for 2 h on the surface of hollow fiber 
membranes was not sufficient to be detected by the ATR-FTIR technique.  
4.2 Transport properties of the membranes 
Morphology related parameters of the membranes were described in previous chapter. However, 
“dynamic” characterization techniques are always necessary since they involve only active pores. 
Among such techniques flow and rejection measurements are among the most relevant ones to the 
current project. First, pure water flux experiments were used to investigate the effect of the coatings. 
And second, rejections of such proteins as BSA and IgG were studied to model the behavior of the 
coated membranes in the bioreactor conditions. 
a 
b 
Fig. 4.3. ATR-FTIR spectra of HCO 1100 (a) and MicroPES TF10 (b) membranes: 1 – virgin 
membrane; 2 – L-DOPA coated membrane; 3 – L-DOPA and Col IV coated membrane. 
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Pure water flux test is a robust, sensitive, easily reproducible and established “dynamic” 
technique used for membrane characterization. Pure water fluxes of the unmodified and coated HCO 
1100 and MicroPES TF10 membranes are presented in Figs. 4.4 and 4.5 respectively. 
Transmembrane pressure range for the experiments selected was 100 – 200 mbar which 
correlates to the pressure diapasons used in haemofiltration treatments [24]. It can be seen from the 
graph, that for HCO 1100 membrane the increase in the fluxes of the coated membranes was observed. 
The increase of the fluxes, in fact, indicates that the alteration in the hydraulic radiuses of the pores 
resulted from coatings do not contribute to the extent it could be recognized by this technique. Instead, 
such alterations in the chemical structure, such as hydrohpilization of the surface, in particular, could 
determine membrane behavior. 
Such assumptions in the above are supported by the literature data available on the 
polydopamine coatings. In fact from the recent studies provided by the different authors [79,84,104] it 
can be estimated that the coating layer thickness under the performed conditions (see 3.3) could not 
exceed 5 nm. Since only the outer surface of the membranes was subjected to coatings without 
applying TMP, selective skin layer of the membrane is expected to be mainly not affected by poly-L-
DOPA the coating. Coating effect on the skin layer will be mainly discussed when describing protein 
rejection measurements in this chapter below. Charge effects of the poly-L-DOPA coatings, according 
to the paper of Azari and Zou [84] were also considered to be negligible, for the same reason as it was 
discussed above, since the nanometer scale coatings could not contribute significantly to the net 
overall charge. On the other hand, even the very thin nanoscale coatings of polydopamine are reported 
to contribute to surface hydrophilization. Positively and negatively charged moieties of the deposited 
layer establish ionic interactions with water molecules dipoles, as described in section 2.5.3. 
Consequently, data showed in Fig. 4.5 for permeate flux of native and modified MicroPES 
TF10 membranes is consistent with the above considerations. As it could be seen from the graph, 
hydraulic permeability of the membranes exceed the corresponding data for HCO 1100 membrane on 
one order of magnitude, which is also expected for a microfiltration range membrane. However the 
effect of the coating on MicroPES TF10 membrane could not be detected by means of the pure water 
flux technique since the  changes in the permeability caused by the coating could be regarded as 
negligible when applied on the much more open, microfiltration range membranes. 
 
Fig. 4.4. Pure water flux of HCO 1100 membranes. 
 
0 50 100 150 200
0
50
100
150
200
250
300
350  Unmodified Membrane (n=6)
 L-Dopa Coated Membrane (n=6)
L-Dopa+Col IV Coated Membrane (n=3)
Pe
rm
ea
te
 F
lu
x 
(L
/m
2  *
h)
Transmembrane Pressure (mbar)
 
 
 28 
Numeric values of hydraulic permeabilities were calculated using Eq. 3.1 after performing 
linear regression and one sample t-Test on the obtained data. Consequently, numeric value of 
hydraulic permeability of HCO 1100 membranes were equal to 0.997±0.036 𝐿
𝑚2∙ℎ∙𝑚𝑏𝑎𝑟
 for unmodified 
membrane compared to the values of 1.352±0.156 and 1.393±0.066 𝐿
𝑚2∙ℎ∙𝑚𝑏𝑎𝑟
 for L-DOPA coated and 
L-DOPA/Col IV double coated membrane respectively. Pairwise comparison between the 
permeability values obtained for virgin and single or double coated HCO 1100 membranes was 
performed using two sample one tailed t-Test. One tailed test was used since it was evident (Fig. 4.5) 
that hydraulic permeabilities of the both single and double coated membranes were higher compared 
to the native membrane. After assuming equal variances, p-values for the tests were calculated and 
were equal to 1.43∙10-4 (n1=n2=6) and 2.46∙10-4 (n1=6, n2=3) respectively, which is in the both cases 
less than the significance value 0.05. Therefore, with the significance level 0.05 it could be stated that 
single and double coatings of HCO 1100 membranes resulted in the increase of its hydraulic 
permeability. 
Similar data treatment was performed for the results obtained for MicroPES TF10 membranes. 
Hydraulic permeabilities for virgin, single coated and double coated MicroPES TF10 membranes were 
equal to 17.12±1.51, 16.32±1.65, 15.52±0.19 respectively. Two sample two tailed t-Test was 
performed to compare the data for virgin and coated membranes. No statistically significant difference 
was observed when comparing permeabilities of virgin and single coated membrane (p=0.450, n1=6, 
n2=4) or virgin and double coated membrane (p= 0.60, n1=6, n2=2). The values of hydraulic 
permeability for coated and unmodified membranes is given the in following diagrams (Fig. 4.6). 
 
Fig. 4.5. Pure water flux of MicroPES TF10 membranes. 
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The membranes behavior in hemofiltration conditions was estimated with the model solutions 
of 1 mg/ml of BSA and 0.02 mg/ml IgG in PBS. Typical protein ultrafiltration curve depicting 
permeate flux vs. TMP was obtained for HCO 1100 membranes for both protein solutions (Fig. 4.7). 
In a tangential flow filtration operation permeate flux increases with increasing TMP up to a 
point (operating point or critical) when it levels off. In the cases of both proteins this value is 
estimated as 0.15 bar. The part before this point is defined as pressure dependent regime and part of 
the graph to the right of the operating point is called pressure independent regime. As it could be seen 
from the graphs, flux curve is reaching the pressure independent or plateau region at 0.2 bar. 
Therefore, the presented results enable us to conclude that the operation curves of coated and native 
PES membranes are consistent with the behavior of typical PES ultrafiltration membranes [95]. 
However, when analyzing protein filtration curves it could be denoted that the increase of the 
flux no longer took place for single and double coated membranes in case of protein solution 
ultrafiltration. This fact could be stated by overlapping of confidence intervals in the graph, that the 
single coating of L-DOPA did not affect the permeate flux. Moreover, in the case of double coated 
with L-DOPA and collagen IV HCO 1100 membranes a decrease of permeate flux was observed. The 
 
 
 
 
 
 
 
 
 
 
 
 
 
a 
 
 
 
 
 
 
 
 
 
 
 
 
 
b 
Fig. 4.6. Hydraulic permeabilities of virgin and coated HCO 1100 (a) and MicroPES TF10 (b) 
membranes. 
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b 
Fig. 4.7. Operational curve of HCO 1100 membrane for filtration of  BSA (a) and IgG (b) solutions. 
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latter effect can be correlated with the decrease in hydraulic radiuses of the pores resulting from 
collagen IV immobilization. 
Different assumption could be made to establish the mechanism of the phenomena. In such 
attempt intrinsic fouling of the membrane could be considered [105,106]. First of all, the presence of 
collagen IV immobilized in the membrane wall would naturally reduce hydraulic radiuses of the pores. 
Additionally it could serve as secondary adsorption site for proteins transported to the permeate side, 
increasing the overall effect on the hydraulic radius. However, additional experiments are required to 
investigate the effect of coating on active pore size distribution of the membrane. 
Utterly different behavior of the flux curve of MicroPES TF10 (Fig. 4.8) membrane was 
observed for filtration of the same protein solutions. Dramatic flux decrease was observed when 
operating at higher pressures in the case of both proteins filtration which is indicated by the negative 
overall negative slope of operation curves. However, even in its lower points (at the highest TMP 
value), permeate fluxes obtained for MicroPES TF10 membranes were significantly higher compared 
to HCO 1100. 
Analyzing the data available in literature [107,108], the probable explanation of the effect, as 
well as the behavior of the filtration curve itself is the deposition of aggregated/denaturated proteins 
on the membrane surface. Protein concentration in the bulk, operating conditions, protein and solvent 
properties play critical role in the process. Specifically, similar behavior of the flux curve of 0.16 μm 
PES microfiltration membrane during the filtration of BSA solution in PBS was reported by Kelly et 
al. [108]. Taking into account that the active pore size of MicroPES TF10 membrane is equal to 0.2 
μm, the proposed model could be used to explain observed phenomenon. According to the authors, 
protein aggregates or denaturated proteins tend to form deposited layers on the relatively open 
structures of PES microfiltration membranes. Alternatively, formation of thiol-disulfide linkages in 
protein molecules during microfiltration, according to Kelly and Zydney [109] was greatly responsible 
for protein aggregation. Higher permeate fluxes (~ 2 fold) observed during IgG microfiltration support 
the above considerations. Moreover, the decrease in permeate flux for the coated MicroPES TF10 
membranes is well aligned with the described models. The ability of poly-L-DOPA layer to form 
conjugates with proteins was discussed in section 2.5.3. Therefore, it is highly probable that the 
coating of the membranes decrease the fouling resistance of MicroPES TF10 membranes. 
Rejection properties of modified and native membranes were evaluated with apparent sieving 
coefficient during protein filtration using Eq. 3.2. For native, single coated and double coated HCO 
1100 membrane these values were equal to 0.234±0.005, 0.231±0.0329 and 0.069±0.0195 
respectively. Assuming the equal variances two sample two tailed t-Tests were performed to establish 
statistical difference of the data. At the level of 0.05, the difference between BSA sieving coefficients 
of virgin and L-DOPA coated membrane was not established (p=0.9008, n1=n2=3). However, BSA 
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b 
Fig. 4.8. Permeate flux of MicroPS TF10 membranes during filtration of BSA(a) and IgG (b) solutions. 
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sieving coefficient was significantly different at when comparing virgin and double coated HCO 1100 
membranes (p=0.0073, n1=3, n2=2).  
Membrane sieving properties for IgG permeation were similar for the previous data. Decrease in 
IgG sieving coefficient from 0.353±0.037 to 0.114±0.019  was observed when comparing virgin and 
double coated HCO 1100. Statistical significant difference was observed using t-Test as described 
above (p=0.0039, n1=3, n2=2). Observed sieving coefficients for both protein solutions obtained with 
virgin and coated HCO 1100 membranes are visualized in the following graph. 
Microfiltration range MicroPES TF10 membranes are of significantly more open structure 
compared to HCO 1100 and are transparent to the proteins (Appendix D) [99,98]. Therefore main 
interest in protein sieving experiments was in the effect of the double coating, which was intended to 
use for cell culture experiments. Results obtained from the permeation tests, however, showed that 
BSA sieving coefficients of single or double coated MicroPES TF10 membranes were equal to 
0.967±0.0116 and 0.967 ±0.005 respectively which is comparable to the data found in literature. 
IgG sieving coefficients of virgin and  coated with L-DOPA and collagen IV MicroPES TF10 
membranes were also determined. Obtained respective values of 0.97±0.021 and 0.875±0.015 were 
statistically different when the sets of data had been compared with two sample t-Test (p= 0.0367, 
n1=n2=2). Sieving coefficients for the MicroPES TF10 membranes are shown in Fig. 4.10. 
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b 
Fig. 4.9. BSA (a) and IgG (b) sieving coefficients of HCO 1100 membranes. 
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b 
Fig. 4.10. BSA (a) and IgG (b) sieving coefficients of MicroPES TF10 membranes. 
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In general, sieving coefficients data is consistent and well aligned with the above consideration 
concerning membrane permeabilities towards protein solutions. On the example of HCO 1100 and to 
less extent MicroPES TF10 membranes it could be established that double coating resulted in decrease 
of sieving coefficient or increase of membrane rejection. The effect was much less pronounced for 
MicroPES TF10 membranes, however, the data from literature [110] provides information that 
protein-fouled microfiltration membrane obtain ultrafiltration rejection properties in temporal 
perspective. 
4.3 Cells attachment and proliferation 
Prior to the bioreactor assembly, seeding and incubation investigation of growth parameters of 
the subculture of human proximal tubular cells was performed. The common technique for studying 
proliferation behavior of the cell is the growth curve. From a growth curve it is possible to estimate 
doubling time of the cells in culture and also cell density at the confluence level. Moreover, during the 
experiments it is possible to investigate cell morphology and the growth patterns. Thereafter, using the 
obtained information of the cell behavior and literature data 
4.3.1. Preliminary characterization of the cell line 
In order to build the growth curve of the culture of human proximal tubular cells standard tissue 
culture 12-well plates were used. Cell suspension of different cell densities were seeded in the plate 
and harvested after the defined periods of time. Tree seeding cell densities were used: 5400 cells/cm2, 
16200 cells/cm2 and at nearly confluent 54000 cells/cm2. Cell performance can be visualized in the 
following graph. 
After observing the graph it could be noticed that in the all cases before the cell proliferation lag 
phase occurred in the period of 0 - 24 hours of the culturing. Next, lag phase was followed by the 
region of exponential growth. The data obtained for the period could be used to estimate the doubling 
time of the population. Finally, the third terminal plateau region could be distinguished when 
 
Fig. 4.11. Human proximal tubular cells growth curve. 
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analyzing the curve with the highest seeding density. Density limitation or contact inhibition is the 
commonly accepted explanation for the phenomenon for the cultures of renal primary cell lines [111]. 
Moreover, as it can be observed from the transmitted light microphotographs (Appendix F), that 
after reaching the confluence the cells formed superconfluent multilayer structures under the 
conditions applied. Formation of dome-shaped multilayer structures was observed in this case. Again, 
such behavior of  renal primary cell lines was previously described in literature and can be controlled 
by varying the composition of the growth factors and nutrients. Serum free defined growth media are 
typically preferred in this respect [112,113]. Therefore when quantifying the confluent cell density the 
both cells counts and microscopy observations are required. 
Important parameters for the further were established in the cell line characterization stage. 
Overall, typical behavior for monolayer culture growth curve was observed in Fig. 4.11 [66]. Doubling 
time of the cell populations seeded with different cell densities was calculated according to the Eqs. 
3.3. First, regions of the growth curves corresponding to the exponential growth were fitted 
exponentially to obtain the values of the specific growth rates. Values of μ obtained from exponential 
fit for the curves 1 – 3 were equal 0.0205 (R2=0.987), 0.014 (R2=0.993) and 0.0062 h-1 (R2=1) 
respectively. Consequently the corresponding doubling times for the curves (Eq. 3.3 b) were 
calculated as 34, 49 and 110 hours. The obtained results are consistent with the above considerations, 
as the highest growth rate was obtained for the smallest seeding density and contact inhibition effects 
were the lowest. 
Confluency levels of the cell populations were determined using cell counts and microscopy 
observations as discussed earlier. For this reason the data obtained for growth curve No. 3 was 
excluded from the calculation as the multilayer structures were determined in the last days of 
cultivation. The obtained value of confluent cell density was thereby determined as 75.2∙103±5.9∙103 
cells/cm2. However, it must also be mentioned that the results that were obtained for tissue culture 
multiwell plates could not be directly extrapolated onto such systems as cell culture flask or 
bioreactors. Access for oxygen, nutrients and the growth factors in the investigated system would 
differ when culture flask are used, for example. Such effect seems evident since volumes of the 
medium per unit surface are proportionally higher for multiwell plates. 
Information of the lag-phase duration, as it is shown later will be used for the further 
experiments. Furthermore, microscopy observations during the cell attachment process to the tissue 
culture plates surface after seeding indicated that the cells were able adhere during 1 h after the 
seeding. During the specified time rounded suspended cells started to elongate upon the contact with 
the surface and were immobilized. These results, lag phase duration data, confluency level and 
doubling time will be used afterwards when developing the strategy for seeding and maintaining 
bioreactor system. 
It should be also mentioned, that when culturing the cell for the large number of passages (up to 
7th) loss of the phenotype of the cells was observed. In such conditions, cells tend to form elongated 
structures, typical for fibroblasts cultures [113]. Therefore in the performed experiments HPTCs were 
used up to passage V. 
Thereafter the performance of the human proximal tubular cells was evaluated using flat coated 
50 kDa PES membranes (Sartorius Stedim Biotech, Gettingen, Germany). Seeding protocol on the flat 
membranes was adapted from the work of the partners on Bioart Consortium [114] which was 
developed for culturing of immortalized renal cell line ciPTEC [115] and is currently being prepared 
for publications. In short, small exposure times when applying single or double coatings were used 
since the process was facilitated by the gravity and the flatness of the surface further contributed to 
homogenous coating formation. Results of the experiments were evaluated with the immunostaining 
for ZO-1 protein, indicator of tight junction formation in monolayer structure and shown in Fig 4.12. 
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As it could be seen from the photographs, the optimal performance of the cells was detected 
when  double coated flat PES membranes were used. Chicken wire-like structures could be recognized 
in Fig. 4.12 (c) which signified proper tight junction formation within  the monolayer. Upon the 
applying of single L-DOPA coating the cells performed better comparing to the virgin membranes, as  
the formation of tight junctions could still be detected, however the pattern of its formation was no 
longer regular. Overall these results are well aligned with the considerations described on biomimetic 
coatings in section 2.5.3. 
4.3.2 Cell attachment in hollow fiber bioreactors 
Adhesion of the primary cell to the surface of hollow fiber membranes was among one of the 
first challenges needed to overcome in order to obtain homogenous confluent monolayers. In case of 
monolayer formation on the flat surface, adhesion process is facilitated by the gravity forces and the 
properties of the surface. Therefore obtaining promising results in cell attachment could be the first 
step for the monolayer formation strategy in the hollow fiber membranes. 
Several approaches were used to facilitate cell attachment. For example, application durations 
of single and double coatings in hollow fiber bioreactors (see section 3.3) were increased significantly 
compared to the procedures performed for flat fiber membranes. First, L-DOPA coatings were applied 
in the dynamic flow conditions allowing easy scale up. And second, drying, washing and collagen IV 
adsorptions steps were also adjusted in respect to the hollow fiber module system. 
Further, the application of short-term negative pressure in the cell suspension compartment was 
assumed to facilitate the cell attachment. Therefore, considering the results of the described above 
experiments and the literature data, human proximal tubular cell performance were tested in  data in 
the bioreactor conditions with double coated HCO 1100 and MicroPES hollow fiber membranes. 
Unmodified membranes served as a negative control. 
Inner surface area of the hollow fiber module available for the cell attachment was estimated as 
~10 cm2. However only ~1 cm2 corresponded to the surface area of the PES membranes and the rest of 
the inner area of the module was related to the surface of the housing. Therefore it was decided to 
perform seeding with suspension of relatively high cell concentration (5∙105 cells/ml) which 
corresponded to the total estimated seeding density ~ 5∙104 cells/cm2. Which, in turn, is in the range of  
the seeding cell density depicted by curve No. 3 in Fig. 4.11. Of course, the specified seeding density 
in hollow fiber membranes do not imply 100% attachment to the surface as it can be expected in flat 
surfaces. 
Also it was decided to discard the cell suspension after 1 hour interval which was estimated as 
the minimal time required for cell attachment. In this manner, the excess of the suspended cells or the 
cells that could not attach to the polypropylene housing was removed from the bioreactor. Attachment 
of cells to the hollow fiber membranes of both types evaluated 24 hours after seeding by fluorescent 
DNA staining with 4',6-diamidino-2-phenylindole (DAPI) is shown in the following figure. 
 
 a  b  c 
Fig. 4.12. Immunostaining for tight junction ZO-1 protein (red) of primary tubular proximal cells after 
one week incubation on unmodified (a), L-DOPA coated (b) and double coated with L-DOPA and Col 
IV flat PES membranes. Staining for rabbit ZO-1 antibody was performed with goat anti-rabbit Texas 
Red labeled secondary antibody. 
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From the figure it could be recognized that the highest cell densities and more homogeneous 
cell distributions were observed when negative pressure was applied. Passive cell attachment for the 
coated membrane also yielded sufficient results, and significantly reduced cell numbers attached to the 
native membranes were observed. Another feature that can be observed from Fig. 4.14 is the 
MicroPES TF10 membrane was more favorable for the cell attachment in all three conditions applied 
as the higher cell densities were observed compared to the respected HCO 1100 samples. 
To quantify and evaluate cell viability after attachment cells adherent to hollow fibers were 
trypsinized and harvested according to the procedure described in section 3.7. Cell harvesting 
trypsinization and harvesting step is required to confirm fluorescent technique, since cell density and 
distribution could be affected by the staining procedure. This is especially significant when the cells 
were only 24 hours after the seeding, since the young cells do not yet establish maximal adhesion with 
the substrate. 
The results of the cell harvesting and counts are presented in Table 4.1. As it could be seen from 
the table the results are consistent with the ones presented in  Fig. 4.13. However the error of cell 
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Fig. 4.13. DAPI fluorescent staining for the nuclei of cells attached to the surface of HCO 1100 (a, 
c, e) and MicroPES TF10 (b, d, f) membranes: a, b – negative pressure applied, double coated 
membranes; c, d – passive adsorption, double coated membranes; e, f – passive adsorption, 
unmodified membranes. 
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counting with haemocytometer chamber is related to significant error and more sensitive method of 
cell counting may be considered for future applications. 
 
Summarizing the obtained results, it becomes evident that applying negative pressure facilitated 
the cell adhesion. However, passive cell attachment onto the surface of the double coated membranes 
showed also satisfactory results. MicroPES TF10 membranes scored better than HCO 1100 in all the 
conditions tested. Such result, most probably related to the surface morphology of the membrane, 
which was adapted to retain blood cells and have dimensions of the pores comparable to the cell size. 
4.3.3 Investigation of monolayer formation in batch bioreactor conditions 
Cells were cultivated in semi-batch type conditions as described in section  3.6 for 7 days. First, 
after module disassembly fibers were removed and prepared for fluorescent analysis. Cell density on 
the hollow fibers was established using fluorescent staining for nuclei with DAPI. As it could be seed 
from Table 4.2 cell densities on the coated fibers exceeded near-confluency levels determined for 
tissue culture multiwell plate. 
 
 
Number of nuclei indicating viable cells were counted in 10 different areas of 100 × 100 𝜇𝑚 
grid and thereafter averaged. When analyzing the obtained data it becomes evident that cell counts are 
generally higher than the counts obtained for the attachment assay indicating the cell growth. 
Surprisingly, the cell density the both membrane at passive adhesion conditions exceeded the 
confluency levels estimated for multiwell plates and no multilayer structures were detected. The most 
probable explanation for the phenomenon is in the more hydrophilic nature of the modified 
membranes compared to tissue culture polystyrene. Consequently, cell spreading is significantly 
reduced in hydrophilic surfaces. Differentiation of epithelial layer and formation of the brush border 
layer could also contribute to the increased cell density compared to the conditions present on tissue 
culture polystyrene. Increase of vertical dimension of the cells is expected in this case [116]. 
Fluorescent DAPI staining showing the nuclei of the cells attached to hollow fiber membranes are 
given in the following photographs. 
 
Table 4.1. Cell densities on the hollow fiber membranes 24 h after the seeding 
 Cell density, ∙10
3cell/cm2 
HCO 1100 MicroPES TF10 
Negative pressure applied, 
double coated membranes 27±13 48 ±1.7 
Passive adhesion, double 
coated membranes 18±3.4 21.4±5.6 
Passive adhesion, unmodified 
membranes 8.0±1.0 13±3.2 
Table 4.2. Cell densities on the hollow fiber membranes after 7 days in culture 
 Cell density, ∙10
3cell/cm2 
HCO 1100 MicroPES TF10 
Negative pressure applied, 
double coated membranes 60±23 46±28 
Passive adhesion, double 
coated membranes 106±25 92±37 
Passive adhesion, unmodified 
membranes 24±21 77±32 
 
 
 37 
As showed in Fig. 4.14. the highest cell density is observed for double coated membranes when 
no negative pressure was applied. The cells were homogeneously distributed in both hollow fibers. 
Less homogeneous cell distribution is observed for the samples with applying the negative pressure, 
and irregular pattern of cell growth was observed for the native membranes. As indicated by cell 
counts, amounts of cells proliferated on the native MicroPES membranes are higher compared with 
the HCO 1100 counterpart, which is well aligned with the previous results. 
From the detailed view of the graph it could be also recognized that the nuclei of irregular shape 
are present in Figs. 4.14 (a) and (b). Such conditions could indicate loss of the cell viability. As a 
contrast, in the rest of the photographs the majority of the nuclei were of the rounded oval shape [117]. 
For further investigation of the cell properties immunostaining for tight junction component – 
ZO-1 protein was performed. First, the conditions with passive adhesion of the cells onto double 
coated membranes are presented (Figs. 4.15 – 4.16). 
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f 
Fig. 4.14. DAPI fluorescent staining for the nuclei of cells attached to the surface of HCO 1100 (a, c, 
e) and MicroPES TF10 (b, d, f) membranes after 7 days of culture: a, b – negative pressure applied, 
double coated membranes; c, d – passive adsorption, double coated membranes; e, f – passive 
adsorption, unmodified membranes. 
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As it could be noticed from the picture, the formed cell monolayers expressed tight junctions 
which indicates functional differentiation. Despite no visible gaps between the cells was observed in 
the microscope, tight junction formation pattern only in some regions repeats chicken wire-like 
structures indicating the formation of the contacts on the perimeter of the cell. Whereas in some 
regions ZO-1 protein could only be partly recognized. However, the expression levels and patterns of 
ZO-1 protein of the HPTCs cultivated on double coated HCO 1100 membranes were comparable or 
even superior to the results obtained for the flat PES membranes (Fig. 4.12) or literature data 
(Fig. 2.10 (c)) [54]. Also it must be noticed that aligned in the direction of the fiber more elongated 
cell morphologies were observed when compared to the cells cultivated on the flat membranes. 
Hollow fiber curvature could play a role in this alignment and is connected with up-regulating of cell 
differentiation [117]. 
Cell density counts obtained for MicroPES TF10 membranes after 7 days culture were 
surprisingly lower compared with HCO 1100 counterpart (Table 4.2). However the cell density 
registered and the cell distribution still imply the formation of the functional monolayer. Tight 
junction formation in double coated MicroPES TF10 membrane is depicted in Fig. 4.16. 
As it could be seen from the picture levels of ZO-1 expression are lower compared to the 
previously described. Formation of chicken wire-like structures are more rare and the ZO-1 patterns 
tend to be more irregular. Cells have still elongated shape, however their orientation is no longer in the 
direction of the fiber but rather at the sharp angle to it. Such behavior is observed throughout the 
length of the fiber. As it was discussed previously increased membrane curvature of HCO 1100 
membranes could play major role in the phenomenon. Therefore the effect of membrane curvature 
could play one of the detrimental roles in epithelial cell differentiation and needs to be further 
investigated. 
 
 
 
Fig. 4.15. Immunostaining for tight junction ZO-1 protein (green) of primary tubular proximal cells after 
one week incubation on double coated with L-DOPA and Col IV hollow fiber HCO 1100 membranes. 
Staining for rabbit ZO-1 antibody was performed with goat anti-rabbit Alexa 488 labeled secondary 
antibody. 
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Next, properties of monolayers for the conditions with applying negative pressure were 
investigated. The results of the fluorescent staining for the cellular tight junctions are presented in 
Fig. 4.17. 
 
 
 
Fig. 4.16. Immunostaining for tight junction ZO-1 protein (green) of primary tubular proximal cells after 
one week incubation on double coated with L-DOPA and Col IV hollow fiber MicroPES membranes. 
Staining for rabbit ZO-1 antibody was performed with goat anti-rabbit Alexa 488 labeled secondary 
antibody. 
 
 
 
 
 
 
a 
 
 
 
 
 
 
b 
 
Fig. 4.17. Immunostaining for tight junction ZO-1 protein (green) of primary tubular proximal cells after 
one week incubation on double coated with L-DOPA and Col IV HCO 1100 (a) and MicroPES (b) 
membranes. Negative pressure applied for the seeding. 
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As it could be seen from the Fig. 4.17, no confluent monolayer formation was detected. At 
higher magnifications (Fig. 4.17 a) gaps in the sell structure could be recognized. Tight junction 
formation also was significantly reduced and no chicken wire-like structures were present. All of 
above could indicate impaired properties of the cells present on the membranes. Cell counts data 
before and after cultivation indicate that ~ 2-fold increase in cell density, which is significantly lower 
than ~ 5 times increase for the bioreactors seeded with passive cell adhesion. Two factors could be 
responsible for the effect. First, seeding density that resulted from applying of the pressure was too 
high, and the cells experienced contact inhibitions, and were unable to spread and form tight junctions 
[66]. Second, the cells were damaged under applying of the pressure [99]. Therefore the both effects 
need to be further investigated by applying range of regulated pressures and using seeding suspensions 
of lower cell concentrations. 
According for the nuclei staining data cell monolayers in the bioreactors with unmodified 
membranes were not formed. Which was indicated by the cell densities and their distribution. Staining 
for ZO-1 protein confirmed previous results (Fig. 4.18). 
The results obtained for unmodified membranes are consistent with the cell counts and the 
literature data, indicating that PES surface modification is required for successful cell attachment and 
proliferation. 
Specific strategies could be applied to improve the monolayer properties. If nutrients or oxygen 
levels were the limiting factor, using the flow system with recirculation could improve these 
parameters. Also according to the literature [44,88] up to 14 days was needed to obtain differentiated 
monolayers, therefore cultivation time could be also increased and its effect investigated.  
Optimization of the coatings could be anther strategy to improve cell adhesion and performance. 
Two approaches could be distinguished in this topic. First, optimization of the parameters of 
application existing components namely collagen type IV and L-DOPA could be performed. 
Concentration of collagen IV applied for performing the double coatign could be increased and in the 
cell performance tested for example in the range of 25 – 200 μg/ml. Another approach would include 
enlarging the number of components used in ECM coating. Among the strategies that could be 
performed on the hollow fiber membranes are using cell feeder layers with following decellularization 
 
a 
 
b 
Fig. 4.18. Immunostaining for tight junction ZO-1 protein (green) of primary tubular proximal cells after 
one week incubation on virgin HCO 1100 (a) and MicroPES (b) membranes. 
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[20], using complex ECM protein mixture such as Matrigel [88]or using different defined 
compositions of ECM proteins. The last option in the list is preferable since in the define ECM 
composition it would be possible to investigate the effect of each component on cell proliferation. 
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5. CONCLUSIONS AND FUTURE PERSPECTIVES 
Biomimetic coatings were developed and applied on the outer surface of two 
commercial hollow fiber membranes HCO 1100 and MicroPES TF10. The properties the 
coated membranes were investigated in the current work and the results of the investigation 
showed that: 
• Increase in pure water permeability of the coated HCO 1100 membranes was observed. 
Membrane surface hydrophilization was assumed as the major factor responsible for the 
experimental effect; 
• Protein permeation experiments revealed that significant decrease in permeate flux for 
double coated membranes of the both types; 
• Rejection properties of the membranes could be tuned with applying the double coating. 
Specifically BSA and IgG sieving coefficients of HCO 1100 hollow fibers decreased 
from 0.214 ± 0.037  and 0.352±0.0370 respectively  for the native membrane compared 
to the values of 0.069 ± 0.019 and 0.114 ± 0.019 for the double coated membranes. 
Small effect of the double coating applied on MicroPES TF10 membranes in protein 
sieving was observed; 
•  Significant increase in cell attachment onto the surface of  double coated hollow fiber 
membranes of both types was demonstrated;  
• Functional confluent monolayers of human primary tubular cells were obtained 
on the outer surface of double coated hollow fiber membranes when cultivated 
in semi batch bioreactors. Higher degree of cell polarization was indicated for 
HCO 1100 membrane compared to MicroPES TF10 counterpart. 
 
However, after achieving initial objectives further investigations are required to unravel and to 
confirm the exact mechanisms underlying the observed phenomena. Specifically, future strategies 
could be categorized in the two groups. First, additional tests are required to characterize the 
properties of double coated membranes and cell monolayers in the bioreactors. Strategies in the 
second category are intended  to provide dynamic characterization of obtained BAK. 
Specifically, among the characterization methods could be distinguished the following: 
• Develop direct methods of detection and poly-L-DOPA coating. Using UV-vis 
spectrometry, ellipsometry could be applied ; 
• Characterization methods of coated membrane should be extended with wettability and 
surface charge measurements; 
• MWCO of the coated membranes could be detected by using dextrans/latex beads to 
obtain precise information on the effect of coating on the hydraulic radiuses of the 
pores; 
• Investigate the homogeneity and structure of collagen IV coating in double coated 
membranes. Fluorescent techniques could be applied. 
• Fluorescent cell viability assays may be applied to investigate investigate cell 
viability upon different conditions. 
As the next stage of BAK development bioreactor modules should be used and tested in 
dynamic perfusion conditions. After applying the dynamic conditions next investigations of the 
monolayers could be performed: 
• Investigate monolayer integrity using inulin permeation technique; 
• Perform the analysis of toxin removal by the BAK system. 
Improvement of the membrane coatings of the bioreactors could be considered separately. 
Obtained results could be considered as a starting point which can be used to compare effect of new 
coating formulations. Specifically increase of concentration of applied Col IV could improve cell 
polarization. Applying of different components of extracellular matrix, specifically 
glycosaminoglycan could increase viability of the cells in renal assist device.  
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APPENDICES 
 
Appendix A 
Comparison between the parameters of RIFLE and AKIN criteria [6] 
 
 
System Serum creatinin criteria Urine output criteria 
RIFLE Class 
Risk Serum creatinine increase to 1.5-fold OR GFR decrease >25 % from baseline <0.5 ml/kg for 6 h 
Injury Serum creatinine increase to 2-fold OR GFR decrease >50 % <0.5 ml/kg for 12 h 
Failure 
Serum creatinine increase to 3-fold OR GFR 
decrease >75 % from baseline OR serum 
creatinine ≥ 340 μmol/l with acute increase of 
at least 44μmol/l 
Anuria for 12 h 
AKIN Stage 
1 Serum creatinine increase ≥ 26.5 μmol/l or increase to 1.5 – 2.0-fold from baseline <0.5 ml/kg for 6 h 
2 Serum creatinine increase to 2.0 – 3.0-fold from baseline <0.5 ml/kg for 12 h 
3 
Serum creatinine increase to > 3.0-fold from 
baseline OR serum creatinine ≥ 340 μmol/l 
with acute increase of at least 44μmol/l OR 
need for RRT 
<0.3 ml/kg for 24 h 
OR anuria for 12 h OR 
need for RRT 
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Appendix B 
Different groups of uremic toxins [12] 
Free water-soluble low-molecular-weight solutes (N = 45) 
Solute CN CU CMAX MW Group 
1-methyladenosine μg/L 17.1±5.1/10 104.0 ± 56.2/17 216.4 281 Ribonucleosides 
1-methylguanosine μg/L 13.7±16.9/10 41.6 ± 23.8/17 89.2 297 Ribonucleosides 
1-methylinosine μg/L 13.5±3.9/10 620.4 ± 203.4/14 1027.2 282 Ribonucleosides 
ADMA mg/L 0.2±0.06/6 1.6 ± 1.2/10 7.3a 202 Guanidines 
α-keto-δ-guanidinovaleric acid 
μg/L 
<30.2/66 — 140.4a 151 Guanidines 
α-N-acetylarginine μg/L 18.1±24.8/16 328.3 ± 142.6/13 4580.0a 216 Guanidines 
Arab(in)itol mg/L <0.6/33 15.0 ± 9.0/12 33.0 152 Polyols 
Argininic acid μg/L <77.0/66 80.5 ± 56.0/11 197.8a 175 Guanidines 
Benzylalcohol mg/L — 27.0 ± 50.7/17 187.9a 108  
β-guanidinopropionic acid μg/L <3.3/24 28.8 ± 18.3/29 65.4 131 Guanidines 
β-lipotropin ng/L <55.3/10 62.7/22 108.8a 461 Peptides 
Creatine mg/L 9.7±3.3/24 134.0 ± 30.3/29 235.8a 131 Guanidines 
Creatinine mg/L <12.0/23 136.0±46.0/19746 240.0a 113 Guanidines 
Cytidine μg/L <468.0 683.3±287.8/7 1263.6a 234 Purines 
Dimethylglycine μg/L <381.1/33 576.8/18 1040.3a 103  
Erythritol mg/L <0.7/33 9.8±14.0/12 37.0a 122 Polyols 
γ-guanidinobutyric acid μg/L <3.6/24 33.3±16.0/30 1750.0a 145 Guanidines 
Guanidine μg/L <11.8/16 172.9±83.8/13 800.0a 59 Guanidines 
Guanidinoacetic acid μg/L 222.3±79.6/24 383.8 ±143.9/29 693.8a 117 Guanidines 
Guanidonosuccinic acid mg/L 0.03±0.01/16 6.5 ± 3.4/13 47.0a 175 Guanidines 
Hypoxanthine mg/L 1.5±0.5/145 2.0 ± 1.6/65 5.3 136 Purines 
Malondialdehyde μg/L 257.7±81.7/30 428.8 ±170.4/16 769.6 71  
Mannitol mg/L <1.3/33 26.0 ± 25.0/12 76.0 182 Polyols 
Methylguanidine μg/L <7.3/24 773.8 ± 508.8/5 1820.0a 73 Guanidines 
Myoinositol mg/L <10.0/8 94.0 ± 69.0/12 232.0 180 Polyols 
N2,N2-dimethylguanosine μg/L 9.0±4.7/10 236.4 ± 89.7/14 415.8 311 Ribonucleosides 
N4-acetylcytidine μg/L 57.0±17.1/10 159.6 ± 30.8/14 221.2 285 Ribonucleosides 
N6-methyladenosine μg/L 18.5±8.4/10 70.3 ± 53.3/17 176.9 281 Ribonucleosides 
N6-threonylcarbamoyladenosine 
μg/L 
35.5±27.2/10 378.0 ±151.2/17 680.4 378 Ribonucleosides 
Orotic acid mg/L 0.5±1.4/30 6.7 ± 16.0/22 38.7 174 Pyrimidines 
Orotidine mg/L 1.2±1.6/30 20.2 ± 13.5/22 47.2 288 Pyrimidines 
Oxalate mg/L 0.3±0.1/8 4.9 ± 1.4/8 7.6 90  
Phenylacetylglutamine mg/L <4.7 53.3 ± 44.7/6 120.6a 264  
Pseudouridine mg/L 0.5±5.8/30 13.1±21.4/7 86.6a 244 Ribonucleosides 
SDMA μg/L 76.1±21.0/66 640.3±212.1/38 1232.2a 202 Guanidines 
Sorbitol mg/L <0.4/33 3.1±2.1/12 7.3 182 Polyols 
Taurocyamine μg/L <52.2/24 — 121.8a 174 Guanidines 
Threitol μg/L <319.6/33 990.0±920.0/12 5697.4a 122 Polyols 
Thymine mg/L — 2.8±4.2/22 11.2 126 Pyrimidines 
Uracil μg/L <224.0 252.0±154.6/7 448.0a 112 Purines 
Urea g/L <0.4/23 2.3±1.1/16 4.6a 60  
Uric acid mg/L <67.2 83.4±44.5/7 146.7a 168 Purines 
Uridine mg/L 1.5±1.3/30 9.8±11.4/22 32.6 244 Pyrimidines 
Xanthine mg/L 0.5±1.4/180 1.5±0.8/65 3.0 152 Purines 
Xanthosine μg/L 23.9±12.8/10 96.6±62.9/11 222.4 284 Ribonucleosides 
 
Protein-bound solutes (N = 25) 
Solute CN  CU  CMAX  MW Group 
2-methoxyresorcinol μg/L  — 19.6±81.2/17  322.0a  140 Phenols 
3-deoxyglucosone mg/L  0.3 ± 0.1/30  1.7 ± 1.0/27  3.5 162 AGE 
CMPF mg/L  7.7 ± 3.3/7  61.0 ± 16.5/15  94.0a  240   
Fructoselysine mg/L  — 58.1 ± 10.8/10  79.7 308 AGE 
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Glyoxal μg/L  67.0 ± 20.0 221.0±28.0/20  277.0 58 AGE 
Hippuric acid mg/L  <5.0 247.0± 112.0/7  471.0 179 Hippurates 
Homocysteine mg/L  <1.7/24  8.1 ± 1.6/7  26.4a  135   
Hydroquinone μg/L  — 50.6 ± 84.7/17  286.0a  110 Phenols 
Indole-3-acetic acid μg/L  17.5 ± 17.5/7  875.0±560.0/42  9076.9a  175 Indoles 
Indoxyl sulfate mg/L  0.6±5.4/40  53.0 ± 91.5/20  236.0 251 Indoles 
Kinurenine μg/L  <391/7  686.4±178.9/21 952.6 208 Indoles 
Kynurenic acid mg/L  <1.0 — 9.5a  189 Indoles 
Leptin μg/L  8.4 ± 6.7/56  72.0 ± 60.6/8  490.0a  16000 Peptides 
Melatonin ng/L  26.5 ±7.1/35  175.8±130.2/13  436.2 126 Indoles 
Methylglyoxal μg/L  47.0±12.0/15  110.0±18.0/20  146.0 72 AGE 
N –(carboxymethyl)lysine mg/L  1.1 ±0.3/24  4.3 ± 1.3/44  6.9 204 AGE 
p-cresol mg/L  0.6 ± 1.0/12  20.1 ± 10.3/20 40.7 108 Phenols 
Pentosidine μg/L  51.6 ± 18.8/19  896.0±448.0/24  2964.0a  342 AGE 
Phenol mg/L  0.6 ± 0.2/12  2.7 ± 3.9/10  10.5 94 Phenols 
P-OHhippuric axid mg/L  — 18.3 ± 6.6/13  31.5 195 Hippurates 
Putrescine μg/L  21.1 ± 7.9/10  77.4 ± 27.3/25  132.0 88 Polyamines 
Quinolinic acid mg/L  0.1 ± 0.05/10  1.5 ± 0.9/54  3.3 167 Indoles 
Retinol-binding protein mg/L  <80 192.0±78.0/112  369.2a  21200 Peptides 
Spermidine μg/L  — 97.2 ± 45.0/25  187.2 145 Polyamines 
Spermine μg/L  — 18.2 ± 16.2/25  66.7a  202 Polyamines 
 
Middle molecules (N = 22) 
Solute CN  CU  CMAX  MW Group 
Adrenomedullin ng/L  13.2 ± 4.6/17  41.8± 19.7/29  81.2 5729 Peptides 
Atrial natriuretic peptide ng/L  28.0±12.2/23  202.0±117.3/27  436.6 3080 Peptides 
β2-microglobulin mg/L  <2.0 55.0 ± 7.9/10  100.0a  11818 Peptides 
β-endorphin ng/L  <173.3/10  301.5/22  492.0a  3465 Peptides 
Cholecystokinin ng/L  <20.0 45.9 ± 32.3/38  131.5a  3866 Peptides 
Clara cell protein (CC16) mg/L  <0.1 3.3 ± 2.0/112  12.5a  15800 Peptides 
Complement factor D mg/L  1.9 ± 0.5/5  19.8 ± 4.1/5  26.0a  23750   
Cystatin C mg/L  <1.6 11.8 ± 3.0/112  20.0a  13300 Peptides 
Degranulation inhibiting protein Ic μg/L  321.7±59.7/23  713.7±390.0/125  1631.4a  14100 Peptides 
Delta-sleep inducing peptide μg/L  — 1.5 0.9/7  3.3 848 Peptides 
Endothelin ng/L  20.8 ± 3.8/23  63.0 ± 33.2/12  129.4 4283 Peptides 
Hyaluronic acid μg/L  <124.0/86  215.0±257.0/184  1843.0a  25000 Peptides 
Interleukin-1μng/L  <160.0/15  428.0 ± 134.0/29  1700.0 32000 Cytokines 
Interleukin-6 ng/L  13.3 ± 3.1/28  92.3 ± 117.9/230  328.1 24500 Cytokines 
κ-Ig light chain mg/L  34.0 ± 15.0/15  70.0 ± 60.9/104  287.0a  25000 Peptides 
λ-Ig light chain mg/L  31.0 ± 11.2/15  87.0 ± 60.9/104  328.0a  25000 Peptides 
Leptin μg/L  8.4 ± 6.7/56  72.0 ± 60.6/8  490.0a  16000 Peptides 
Methionine-enkephalin ng/L  <18.3/10  32.2/22  75.5a  555 Peptides 
Neuropeptide Y ng/L  <80.0 64.9 ± 25.5/19  115.9 4272 Peptides 
Parathyroid hormone μg/L  <0.06 1.2 ± 0.6/10  2.4 9225 Peptides 
Retinol-binding protein mg/L  <80 192.0 ± 78.0/112  369.2a  21200 Peptides 
Tumor necrosis factor-μng/L  13.3 ± 3.0/28  114.0±147.0/230  408.0 26000 Cytokines 
 Abbreviations are: CN, normal concentration; CU, mean/median uremic concentration; CMAX, maximal 
uremic concentration; MW, molecular weight, ; CMPF, 3-carboxy-4-methyl-5-propyl-2-
furanpropionic acid; AGE, advanced glycation end products, ADMA, asymmetrical dimethylarginine; 
SDMA, symmetrical dimethylarginine. The underlined numbers behind the slash point to the number 
of data on which the means or medians have been obtained. No underlined number indicates that no 
data about the number of samples were available. No number indicates that no n value was given. 
Normal values are reported as mean ±SD, or in the case of a single value as a maximum (accompanied 
by <); uremic values are reported as mean ±SD or, in the case of a single value, as a median. 
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Appendix C 
HCO 1000 membrane specification [100,118] 
 
Membrane Specifications 
Ultrafiltration coefficient, ml/(h*mmHg) 52 
Inner diameter, μm 300 
Wall thickness, μm 100 
Pore size in selective skin layer, nm 8 - 12 
Membrane Performance 
CL urea, ml/min 199 - 390 
CL phosphate, ml/min 195 - 354 
CL myoglobin, ml/min 126 - 170 
So Vitamin B12 1.0 
So Inulin 1.0 
So Myoglobin 0.95 
So Albumin 0.2 
Dextran sieving curve of HCO 1100 membrane [118] 
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Selective skin layer pore size distribution of several hemodialysis membranes [118] 
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Appendix D 
MicroPES TF10 membrane specification [99,98] 
Membrane Specifications 
Inner diameter, μm 300 
Wall thickness, μm 100 
Maximum pore size, μm 0.5 
Nominal pore size, μm 0.2 
Membrane Performance 
So Albumin 0.99 
So IgG 0.97 
So Fibrinogen 0.88 
So High Density Lipoprotein 1 
So IgM 0.99 
So Low Density Lipoprotein 0.97 
So Cholesterol 0.97 
Latex beads sieving curve of MicroPES TF10 membrane [99] 
 
 
  
 
 
 56 
Appendix E 
Membranes, mini-modules and the setub used in the current work 
 
Mini modules assembled with reusable and dispensable T-shape connectors 
 
 
 
 
 
 
Virgin (white) and L-DOPA coated (darker) HCO 1100 and MicroPES TF10 hollow fiber membranes 
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Setup for membrane transport measurements 
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Appendix F 
Morphology and growth patterns of subconfluent (a), near confluent (b) and 
superconfluent (c) human proximal tubular cells 
 
 
 
 
 
 
 
 
 
a 
 
 
 
 
 
 
 
 
 
b 
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